Secondary and unspecified malignant neoplasm of lymph nodes

C3_LYMPHNODES_SECONDARY_NAS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C77 Cause of death: ICD-8 — 196 Cancer registry: Topography ICD-O-3 — C77 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 2 out of 7 registries used, show all original rules.	3437
4. Check minimum number of events None	3437
5. Include endpoints None	3437
6. Filter based on genotype QC (FinnGen only)	3333

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF9

NAME	C3_LYMPHNODES_SECONDARY_NAS
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C77
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	196
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C77
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Secondary and unspecified malignant neoplasm of lymph nodes based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3333	1489	1844
Unadjusted period prevalence (%)	0.70	0.53	0.84
Median age at first event (years)	62.29	60.75	63.53

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3437: Matched controls
34370

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WF003

NOMESCO Finland

Adjuvant radiotherapy

1691.8

315.3

302

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

162.9

307.7

185

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

230.8

307.7

276

A04AA02

ATC

granisetron; systemic, transdermal

960.8

307.7

693

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

9.0

307.7

618

813

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

6934.6

307.7

1017

D70.82

ICD-10 Finland

Drug-induced neutropenia

114.6

307.7

284

H02AB02

ATC

dexamethasone; systemic

66.0

307.7

807

159

WF002

NOMESCO Finland

Radical radiotherapy

184.2

307.7

392

PJA10

NOMESCO Finland

Exploration of lymph nodes

169.9

307.7

626

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

21.8

307.7

498

265

1XC02, ,

NOMESCO Finland

79.1

307.7

270

WW500

NOMESCO Finland

Blood transfusion

24.2

307.7

542

264

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

126.8

307.7

203

WZC00

NOMESCO Finland

Treatment plan or consultation

4.1

307.7

1644

6252

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

1807.2

307.7

318

EP1AE

NOMESCO Finland

Neck ultrasound examination

11.6

307.7

544

547

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

201.1

307.7

243

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

307.7

331

XX3DW

NOMESCO Finland

Time consuming IT work

9.5

307.7

575

713

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

419.4

307.7

2483

212

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

55.6

307.7

332

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

307.7

453

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

11.5

307.7

465

463

XW000

NOMESCO Finland

Bone marrow biopsy

31.8

307.7

965

417

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

1031.5

307.7

733

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

3834.7

307.7

356

A03FA01

ATC

metoclopramide; systemic, rectal

20.9

307.7

1956

2045

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

128.3

307.7

261

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

236.2

307.7

840

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.5

307.7

821

1857

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

61.2

307.7

218

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

307.7

433

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

25.8

307.7

229

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

1102.8

307.7

556

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

57.8

307.7

1082

271

ZX112

NOMESCO Finland

Subcutaneous

31.2

307.7

239

ZX120

NOMESCO Finland

Intravenous

7.9

307.7

735

1138

JN4BD

NOMESCO Finland

Extensive body CT

27.6

307.7

1310

750

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

307.7

1025

A04AA01

ATC

ondansetron; systemic, rectal

35.4

307.7

922

352

L03AA02

ATC

filgrastim; parenteral

977.4

307.7

979

Z51.5

ICD-10 Finland

Palliative care

11.1

307.7

495

511

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

246.7

307.7

314

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

74.4

307.7

268

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

307.7

611

M04AA01

ATC

allopurinol; systemic

8.4

307.7

1491

2867

JN4AD

NOMESCO Finland

Body CT examination

14.8

307.7

926

837

L03AA13

ATC

pegfilgrastim; parenteral

3007.9

307.7

752

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

307.7

461

JN6AD

NOMESCO Finland

CT of torso and neck

110.5

307.7

517

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

635.9

307.7

493

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

90.5

307.7

624

WF049

NOMESCO Finland

Radiotherapy of metastasis

1042.0

297.3

287

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

294.1

278

N02AA05

ATC

oxycodone; systemic

4.4

292.8

928

2669

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

1516.7

288.5

277

R50.9

ICD-10 Finland

Fever, unspecified

4.4

286.9

908

2605

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

280.1

265

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.5

270.8

801

2175

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

268.3

254

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

266.2

252

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

263.0

249

L03AA14

ATC

lipegfilgrastim; parenteral

2586.7

262.7

251

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2563.8

260.6

249

130

Kela drug reimbursment

Malignant tumour

+∞

258.7

245

C61

ICD-10 Finland

Malignant neoplasm of prostate

885.1

254.5

247

JN4CD

NOMESCO Finland

Very extensive body CT

14.9

253.6

230

165

H02AB06

ATC

prednisolone; systemic

3.3

245.4

2169

11748

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

240.5

228

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

234.1

222

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

229.8

218

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

7.4

225.0

345

511

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

222.3

211

9691/3-C77.9

ICD-O-3

Follicular lymphoma, grade 2 of lymph node, NOS

+∞

219.1

208

TPX10

NOMESCO Finland

Implantation of vascular injection port

10.6

215.5

242

243

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

25.0

213.6

151

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.0

212.7

2031

11165

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

211.7

201

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

+∞

209.5

199

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

10.0

209.3

246

263

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

206.4

196

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

55.0

206.3

117

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

31.6

205.7

134

A04AA55

ATC

palonosetron, combinations; systemic

+∞

205.3

195

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

204.2

194

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

94.6

193.5

101

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

401.3

191.9

191

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

+∞

189.3

180

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.4

188.0

399

812

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

185.1

176

WZC30

NOMESCO Finland

Teaching

3.7

184.4

692

2184

WF004

NOMESCO Finland

Palliative radiotherapy

1966.6

183.9

177

212

Kela drug reimbursment

Gout

8.8

182.2

235

283

PJA12

NOMESCO Finland

Sentinel node biopsy

616.1

179.2

176

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

38.4

175.4

108

H02AB07

ATC

prednisone; oral

3.3

161.5

746

2670

L02AE02

ATC

leuprorelin; implant, parenteral

24.8

159.8

113

115

Kela drug reimbursment

Breast cancer

+∞

156.5

149

9663/3-C77.9

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS

+∞

156.5

149

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

8.4

155.6

209

264

C81.7

ICD-10 Finland

Other classical Hodgkin lymphoma

+∞

155.4

148

C81.2

ICD-10 Finland

Mixed cellularity classical Hodgkin lymphoma

+∞

150.1

143

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

17.9

148.6

121

J05AB11

ATC

valaciclovir; oral

3.2

148.4

699

2521

D70.89

ICD-10 Finland

Neutropenic splenomegaly

16.9

148.0

124

J01MA12

ATC

levofloxacin; systemic

2.9

147.7

877

3607

A02BC02

ATC

pantoprazole; systemic

2.8

146.5

2574

17814

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

12.6

146.3

145

120

WX408

NOMESCO Finland

General anesthesy, balanced

2.7

138.1

1018

4664

WW300

NOMESCO Finland

Transfer of autologic stem cells

700.7

137.8

135

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

7.0

137.4

217

329

TGC00

NOMESCO Finland

Bronchial lavation

7.0

135.7

214

324

HA1AA

NOMESCO Finland

X-ray mammography

6.8

135.3

220

344

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

1351.2

134.3

130

116

Kela drug reimbursment

Prostate cancer

+∞

131.1

125

ZX070

NOMESCO Finland

Intensity modified radiotherapy

447.7

130.9

130

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

1306.6

130.1

126

ZX090

NOMESCO Finland

Other technic of radiotherapy

170.2

125.3

131

A04AD12

ATC

aprepitant; systemic

630.4

124.1

122

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

51.0

121.4

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

8.3

121.0

163

206

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1199.2

119.5

116

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

24.2

119.2

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.4

118.7

487

1601

9591/3-C77.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS

+∞

115.2

110

L02BA01

ATC

tamoxifen; oral

59.3

114.2

B01AB05

ATC

enoxaparin; parenteral

2.4

113.6

1178

6228

TPX15

NOMESCO Finland

Removal of vascular injection port

45.5

113.4

9823/3-C77.9

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS

+∞

112.1

107

XX9CD

NOMESCO Finland

Very extensive complementary CT

+∞

111.0

106

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

108.3

884

4186

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.6

107.7

270

626

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

106.8

102

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

21.8

106.4

ZX108

NOMESCO Finland

Inhalation

17.1

104.9

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

143.3

104.7

111

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

104.7

100

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

20.0

103.7

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

26.8

103.4

9663/3-C77.8

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions

+∞

102.6

B01AB10

ATC

tinzaparin; parenteral

3.5

102.0

386

1201

9591/3-C77.0

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck

+∞

101.6

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.5

100.1

369

1128

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

98.4

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.3

97.9

205

408

L01AA02

ATC

chlorambucil; oral

175.1

97.8

102

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

8.9

97.6

123

143

B72

ICPC

Hodgkin Lymphoma

975.5

97.5

20199

ICD-8 Finland

Hodgkin's disease

+∞

96.3

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

96.3

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

26.9

96.2

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

11.9

94.0

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

22.4

92.5

HAB40

NOMESCO Finland

Wedge excision of mammary gland

17.8

92.3

WX402

NOMESCO Finland

General anaesthesia

2.5

90.2

711

3283

L02BG04

ATC

letrozole; oral

9.2

89.0

109

122

9691/3-C77.8

ICD-O-3

Follicular lymphoma, grade 2 of lymph nodes of multiple regions

+∞

88.9

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

88.5

1077

5969

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

880.5

88.1

2008X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Other named variants

+∞

84.7

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

84.7

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

4.1

84.6

248

646

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

838.5

83.9

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.2

83.8

357

1191

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

83.7

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

5.6

83.7

164

307

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

83.2

735

3558

GD1AD

NOMESCO Finland

Thorax CT examination

3.8

82.7

270

759

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

26.3

82.5

L01CB01

ATC

etoposide; systemic

+∞

81.6

9690/3-C77.9

ICD-O-3

Follicular lymphoma, NOS, of lymph node, NOS

+∞

79.5

9698/3-C77.9

ICD-O-3

Follicular lymphoma, grade 3 of lymph node, NOS

+∞

79.5

A06AH03

ATC

naloxegol; oral

16.2

78.8

I88.9

ICD-10 Finland

Nonspecific lymphadenitis, unspecified

14.9

78.5

L01BC06

ATC

capecitabine; oral

+∞

78.4

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.6

78.3

276

816

NK6AN

NOMESCO Finland

Total body bone isotope imaging

30.4

77.4

A79

ICPC

Malignancy NOS

165.9

77.4

9650/3-C77.0

ICD-O-3

Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck

+∞

77.4

HAC20

NOMESCO Finland

Total mastectomy

140.0

77.3

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

266.5

76.8

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.1

76.2

350

1218

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

+∞

74.2

ZXE00

NOMESCO Finland

One hour or less

2.0

73.6

1343

8504

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.7

72.7

175

391

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

723.3

72.4

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

712.8

71.4

A41.9

ICD-10 Finland

Sepsis, unspecified

4.1

71.0

202

514

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

70.6

987

5679

9663/3-C77.0

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of head, face and neck

+∞

70.0

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

17.5

69.7

WW409

NOMESCO Finland

Other aferesis

349.1

68.8

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.8

68.8

386

1497

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

21.6

68.3

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

6.7

67.2

108

166

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

66.9

JAH00

NOMESCO Finland

Laparotomy

5.1

66.8

145

297

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.9

66.7

205

551

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.6

66.3

437

1836

Y77

ICPC

Malignant neoplasm prostate

176.0

66.3

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

120.8

66.1

7856A

ICD-9 Finland

Symptoms involving cardiovascular system, Enlargement of lymph nodes

27.8

64.8

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

27.8

64.8

KCD02

NOMESCO Finland

Transurethral resection of bladder

13.5

64.8

9673/3-C77.9

ICD-O-3

Mantle cell lymphoma of lymph node, NOS

+∞

64.8

A07AA02

ATC

nystatin; oral

3.2

64.5

274

909

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

+∞

63.7

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

115.6

63.1

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

24.0

62.9

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

6.5

62.7

103

162

Z51.0

ICD-10 Finland

Radiotherapy session

318.6

61.6

C50.99

ICD-10 Finland

Breast, unspecified

608.8

60.9

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.8

60.9

142

309

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

5.6

60.8

117

215

9695/3-C77.9

ICD-O-3

Follicular lymphoma, grade 1 of lymph node, NOS

+∞

60.6

C83.89

ICD-10 Finland

Other types of diffuse non-Hodgkin's lymphoma

+∞

60.6

D69.5

ICD-10 Finland

Secondary thrombocytopenia

22.9

59.0

9680/3-C77.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck

+∞

58.5

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

23.6

58.3

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

12.3

58.3

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

57.7

765

4276

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

57.4

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

57.4

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

57.4

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

57.4

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

57.3

2295

18022

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

73.7

57.2

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

57.2

408

1774

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

6.1

56.7

100

169

GEA00

NOMESCO Finland

Mediastinoscopy

18.2

56.0

WW200

NOMESCO Finland

Immunization

4.3

55.6

146

349

R4190

NOMESCO Finland

Nutritional therapy

4.5

55.6

139

320

9591/3-C77.2

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes

+∞

55.4

2000B

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]

+∞

55.4

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

5.6

55.2

105

191

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

4.1

55.0

157

400

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.7

54.7

313

1222

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

13.2

54.6

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

20.7

54.0

TPJ00

NOMESCO Finland

Biopsy of superficial lymph node

100.1

54.0

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

15.4

53.7

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

7.1

53.4

117

2015X

ICD-9 Finland

Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]

+∞

53.3

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

52.9

1040

6590

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

8.4

52.7

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

6.9

52.6

119

4701

FHL

Neck lymph node removal

67.7

52.3

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

12.3

52.2

9591/3-C77.4

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg

+∞

52.2

WW402

NOMESCO Finland

Leucoferesis

+∞

52.2

L02BB03

ATC

bicalutamide; oral

+∞

52.2

YNB10

NOMESCO Finland

Collection of stem cells for transplant

+∞

52.2

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

52.2

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

8.7

52.1

Z31.6

ICD-10 Finland

General counselling and advice on procreation

10.3

52.0

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

6.3

51.8

140

J05AB01

ATC

aciclovir; systemic

1.9

51.2

756

4364

C83.0

ICD-10 Finland

Small cell B-cell lymphoma

+∞

51.2

1AA09, ,

NOMESCO Finland

+∞

51.2

JAH01

NOMESCO Finland

Laparoscopy

3.9

50.5

154

411

R06AE07

ATC

cetirizine; oral

1.7

50.3

1397

9751

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

50.1

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

+∞

50.1

C84.51

ICD-10 Finland

Other and unspecified T-cell lymphomas

+∞

50.1

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

6.4

50.1

135

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

49.7

595

3188

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

20.2

49.5

JMA10

NOMESCO Finland

Transabdominal total splenectomy

20.2

49.5

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

49.4

442

2115

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.3

49.1

131

317

9673/3-C77.8

ICD-O-3

Mantle cell lymphoma of lymph nodes of multiple regions

+∞

49.1

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.5

48.9

322

1345

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

48.5

1681

12421

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

6.3

48.4

133

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

48.0

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

48.0

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

129.4

47.9

B02

ICPC

Lymph gland(s) enlarged/painful

8.1

47.8

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

11.0

47.8

E83.50

ICD-10 Finland

Hypercalcemia

6.9

47.5

107

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

47.4

1152

7716

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

47.0

9652/3-C77.9

ICD-O-3

Hodgkin lymphoma, mixed cellularity, NOS, of lymph node, NOS

+∞

47.0

C83.33

ICD-10 Finland

Primary medical lymphoma with large B cells

+∞

47.0

ZZR00

NOMESCO Finland

Flap of skin

9.3

46.6

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

5.8

46.4

149

9698/3-C77.8

ICD-O-3

Follicular lymphoma, grade 3 of lymph nodes of multiple regions

+∞

45.9

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

45.9

C84.59

ICD-10 Finland

Other and unspecified T-cell lymphomas

+∞

45.9

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

101.5

45.9

KA1FN

NOMESCO Finland

Isotope renography

11.3

45.8

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

45.4

1005

6539

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

59.8

45.4

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

84.6

44.9

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

44.9

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

6.0

44.3

135

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

43.8

J01MA14

ATC

moxifloxacin; systemic

2.4

43.6

337

1512

N02BE01

ATC

paracetamol; systemic, rectal

2.0

43.3

2952

25871

C03CA01

ATC

furosemide; systemic

1.7

43.3

1144

7800

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

42.8

283

1182

9659/3-C77.9

ICD-O-3

Hodgkin lymphoma, nodular lymphocyte predominant of lymph node, NOS

+∞

42.8

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

+∞

42.8

2009X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]

+∞

42.8

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

42.6

1221

8495

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

3.0

42.5

196

680

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

3.9

42.4

128

339

L57.0

ICD-10 Finland

Actinic keratosis

2.4

42.1

315

1393

TQW99

NOMESCO Finland

Other minor procedure on skin

3.3

41.9

163

511

AA1BD

NOMESCO Finland

Extensive CT of head and brain

4.8

41.8

206

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

41.7

C83.2

ICD-10 Finland

Mixed small and large cell (diffuse) non-Hodgkin's lymphoma

+∞

41.7

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

41.7

C83.32

ICD-10 Finland

Centroblastic diffuse non-Hodgkin's lymphoma

+∞

41.7

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

41.7

H02AB09

ATC

hydrocortisone; systemic

4.3

41.7

110

264

C81

ICD-10 Finland

Hodgkin lymphoma

412.5

41.2

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

68.0

41.1

9699/3-C77.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of lymph node, NOS

+∞

40.7

390

Kela drug reimbursment

Ibrutinib

+∞

40.7

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

5.6

40.2

141

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

402.2

40.2

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

40.1

410

2061

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

5.2

40.1

163

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

207.4

39.9

9659/3-C77.8

ICD-O-3

Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of multiple regions

+∞

39.7

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

39.7

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.3

39.0

102

243

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

202.3

38.9

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

202.3

38.9

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.5

38.8

139

414

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

38.6

C82.7

ICD-10 Finland

Other types of follicular lymphoma

+∞

38.6

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

38.6

C83.35

ICD-10 Finland

T-cell-rich B-cell lymphoma

+∞

38.6

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

38.6

ZXA05

NOMESCO Finland

Left side

1.7

38.5

821

5248

ED1AA

NOMESCO Finland

Mandibular X-ray examination

9.9

38.3

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

381.6

38.1

B01AB04

ATC

dalteparin; parenteral

2.9

38.0

186

666

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

7.2

37.7

C83.01

ICD-10 Finland

Lymphoplasmacytic lymphoma

+∞

37.6

C82.0

ICD-10 Finland

Follicular lymphoma grade I

+∞

37.6

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

36.5

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

36.5

PJ2HT

NOMESCO Finland

Biopsy of deep lymphnode with ultrasound guidance

+∞

36.5

OAA41

NOMESCO Finland

Health check based on individual needs

+∞

36.5

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

36.5

9650/3-C77.9

ICD-O-3

Hodgkin lymphoma, NOS, of lymph node, NOS

+∞

36.5

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

8.9

36.3

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

69.0

36.0

127

Kela drug reimbursment

Transplant complication

5.4

35.9

134

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

5.3

35.5

139

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

35.5

1512

Kela drug reimbursment

Ibrutinib

+∞

35.5

L01BB05

ATC

fludarabine; systemic

+∞

35.5

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

4.4

35.4

210

WX002

NOMESCO Finland

Sedation and analgesia

1.8

35.3

659

4041

Z3231

NOMESCO Finland

Registered nurse

1.7

35.2

868

5750

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.8

35.1

186

695

J01DB01

ATC

cefalexin; oral

1.7

35.0

2673

23156

JAH21

NOMESCO Finland

Staging laparoscopy

181.9

34.8

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

34.4

C83.34

ICD-10 Finland

Anaplastic large cell lymphoma

+∞

34.4

2019X

ICD-9 Finland

Hodgkin's disease, unspecified

+∞

34.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

33.6

1306

9645

9680/3-C77.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes

+∞

33.4

C84.49

ICD-10 Finland

Peripheral T-cell lymphoma, unspecified cell type

+∞

33.4

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

7.8

33.2

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

32.7

354

1812

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

32.3

C83

ICD-10 Finland

Non-follicular lymphoma

+∞

32.3

9695/3-C77.8

ICD-O-3

Follicular lymphoma, grade 1 of lymph nodes of multiple regions

+∞

32.3

C82

ICD-10 Finland

Follicular lymphoma

+∞

32.3

ZXA00

NOMESCO Finland

Right side

1.6

32.3

869

5869

R4110

NOMESCO Finland

Physiotherapy

1.6

31.8

839

5633

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

88.4

31.8

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

31.3

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

31.3

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

31.3

C84.5

ICD-10 Finland

Other mature T/NK-cell lymphomas

+∞

31.3

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.1

31.1

135

452

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

7.8

31.0

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

7.2

30.5

GEA20

NOMESCO Finland

Mediastinoscopy with excision of lesion

31.1

30.3

Z2221

NOMESCO Finland

Medical doctor

1.6

30.3

824

5566

9670/3-C77.9

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph node, NOS

+∞

30.2

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

30.2

20298

ICD-8 Finland

Other neoplasms of lymphoid tissue, Lymphomata alia

+∞

30.2

2000A

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]

+∞

30.2

9591/3-C77.8

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions

+∞

30.2

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

30.2

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

4.3

30.0

181

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

4.8

29.9

145

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

12.1

29.9

L02BG06

ATC

exemestane; oral

305.0

29.8

J94.8

ICD-10 Finland

Other specified pleural conditions

4.6

29.6

154

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

6.7

29.3

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

29.2

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

29.2

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

8.3

29.1

TAB00

NOMESCO Finland

Lumbar puncture

2.6

28.9

167

652

Z2446

NOMESCO Finland

Social worker

2.4

28.9

213

933

N02AX02

ATC

tramadol; systemic, rectal

1.5

28.8

1336

10163

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

+∞

28.2

A41.8

ICD-10 Finland

Other specified sepsis

3.8

28.1

226

C90.0

ICD-10 Finland

Multiple myeloma

100.9

27.7

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

146.2

27.7

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

7.0

27.6

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

27.4

337

1803

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

27.3

214

962

SPAT1153

SPAT

Removal of sutures

1.6

27.3

974

6982

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

27.1

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

27.1

9690/3-C77.8

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of multiple regions

+∞

27.1

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

27.1

C83.71

ICD-10 Finland

Burkitt's tumour

+∞

27.1

9691/3-C77.0

ICD-O-3

Follicular lymphoma, grade 2 of lymph nodes of head, face and neck

+∞

27.1

TGD00

NOMESCO Finland

Needle biopsy of lung

26.7

27.1

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

62.5

27.0

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

273.2

26.8

C50

ICD-10 Finland

Malignant neoplasm of breast

273.2

26.8

J01MA02

ATC

ciprofloxacin; systemic

1.5

26.7

1227

9275

HAB99

NOMESCO Finland

Other partial excision of mammary gland

7.1

26.7

9652/3-C77.8

ICD-O-3

Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of multiple regions

+∞

26.1

9702/3-C77.9

ICD-O-3

Mature T-cell lymphoma, NOS, of lymph node, NOS

+∞

26.1

9650/3-C77.1

ICD-O-3

Hodgkin lymphoma, NOS, of intrathoracic lymph nodes

+∞

26.1

C84.4

ICD-10 Finland

Peripheral T-cell lymphoma, not elsewhere classified

+∞

26.1

9823/3-C77.8

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of multiple regions

+∞

26.1

L01EL01

ATC

ibrutinib; oral

+∞

26.1

J02AC03

ATC

voriconazole; systemic

31.2

25.9

N05CF01

ATC

zopiclone; oral

1.5

25.8

1010

7374

128

Kela drug reimbursment

Cancers of female genital organs

262.6

25.7

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

262.6

25.7

5702

FHL

Local lymph node removal (eg armpit, groin)

94.1

25.7

L01AA01

ATC

cyclophosphamide; systemic

10.1

25.6

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

5.3

25.6

UJF32

NOMESCO Finland

Coloscopy

1.6

25.5

797

5531

JFB00

NOMESCO Finland

Partial resection of small intestine

4.6

25.4

132

9705/3-C77.9

ICD-O-3

Angioimmunoblastic T-cell lymphoma of lymph node, NOS

+∞

25.0

9591/3-C77.1

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of intrathoracic lymph nodes

+∞

25.0

9652/3-C77.0

ICD-O-3

Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of head, face and neck

+∞

25.0

9591/3-C77.3

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm

+∞

25.0

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.8

24.8

119

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

252.0

24.7

3AA13, ,

NOMESCO Finland

252.0

24.7

B02.9

ICD-10 Finland

Zoster without complication

2.1

24.7

235

1144

X76

ICPC

Malignant neoplasm breast female

90.8

24.7

JAH20

NOMESCO Finland

Staging laparotomy

90.8

24.7

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

131.0

24.6

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.5

24.6

A06AD11

ATC

lactulose; oral

1.7

24.6

498

3099

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

6.1

24.5

S18

ICPC

Laceration/cut

1.5

24.3

1389

10907

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

24.2

842

5976

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

24.0

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

24.0

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

24.0

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

24.0

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

24.0

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

24.0

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

24.0

9690/3-C77.4

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of inguinal region or leg

+∞

24.0

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

22.9

23.9

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

67.9

23.8

L01XX52

ATC

venetoclax; oral

241.6

23.7

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

125.9

23.6

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

3.6

23.5

212

ZXD05

NOMESCO Finland

Urgent procedure

1.5

23.4

928

6766

121

Kela drug reimbursment

Severe hypofunction of sexual glands

3.8

23.4

194

A07AA09

ATC

vancomycin; oral

4.1

23.2

155

JAL00

NOMESCO Finland

Biopsy of peritoneum

22.2

23.0

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

22.9

9680/3-C77.4

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of inguinal region or leg

+∞

22.9

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

22.9

9663/3-C77.1

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of intrathoracic lymph nodes

+∞

22.9

C83.8

ICD-10 Finland

Other non-follicular lymphoma

+∞

22.9

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

22.9

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

22.9

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.3

22.9

182

823

A04AA03

ATC

tropisetron; systemic

65.4

22.8

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

65.4

22.8

XX1AD

NOMESCO Finland

Other CT-examination

65.4

22.8

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

84.0

22.7

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.4

22.4

243

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.0

22.3

336

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.5

22.1

216

L01XE27

ATC

[U] ibrutinib

+∞

21.9

9699/3-C77.8

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

21.9

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

21.9

2016A

ICD-9 Finland

Hodgkin's disease, Mixed cellularity

+∞

21.9

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

21.9

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

21.9

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

+∞

21.9

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

21.9

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

21.9

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

21.9

C88.9

ICD-10 Finland

Malignant immunoproliferative disease, unspecified

+∞

21.9

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

21.9

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

221.4

21.6

V03AF03

ATC

calcium folinate; systemic

221.4

21.6

399

Kela drug reimbursment

Venetoclax

221.4

21.6

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.6

21.6

205

JN4DD

NOMESCO Finland

Scout CT scan of torso

115.8

21.6

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

31.3

21.5

D37.00

ICD-10 Finland

Aryepiglottic fold marginal zone

8.3

21.4

S04

ICPC

Lump/swelling localized

1.8

21.3

314

1777

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

6.0

21.2

A02BC01

ATC

omeprazole; systemic

1.5

21.1

855

6239

N05BA06

ATC

lorazepam; systemic, sublingual

2.2

21.1

174

800

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

8.5

21.0

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

60.4

20.9

6103

FHL

Staging laparotomy (to study the reticuloendothelial system)

+∞

20.8

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

20.8

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

20.8

C81.3

ICD-10 Finland

Lymphocyte depleted classical Hodgkin lymphoma

+∞

20.8

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

20.8

9690/3-C77.0

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of head, face and neck

+∞

20.8

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

20.8

9659/3-C77.3

ICD-O-3

Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of axilla or arm

+∞

20.8

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

20.8

529

3479

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

37.4

20.8

PJ2CT

NOMESCO Finland

Biopsy of lymphnode with CT guidance

211.2

20.6

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

4.0

20.5

143

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

20.4

182

863

D48.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Retroperitoneum

25.6

20.4

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

25.6

20.4

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

6.2

20.2

B03XA02

ATC

darbepoetin alfa; parenteral

3.5

20.2

200

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

20.0

126

514

R50.8

ICD-10 Finland

Other specified fever

6.8

20.0

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.8

19.9

101

370

9651/3-C77.9

ICD-O-3

Hodgkin lymphoma, lymphocyte-rich of lymph node, NOS

+∞

19.8

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

19.8

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

19.8

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

19.8

2014A

ICD-9 Finland

Hodgkin's disease, Lymphocytic-histiocytic predominance[MORBUS HODGKIN,""""LYMPHOCYTIC PREDOMINANCE"""",""""NODULAR""""]

+∞

19.8

9680/3-C77.3

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm

+∞

19.8

ZXC96

NOMESCO Finland

Robot assisted procedure

5.8

19.8

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

73.9

19.7

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.8

19.6

161

EP1AE, ,

SPAT

3.9

19.6

152

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

105.7

19.6

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

105.7

19.6

WF099

NOMESCO Finland

Other radiotherapy

24.7

19.5

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.5

19.5

124

508

J01CA04

ATC

amoxicillin; systemic

1.4

19.4

2532

22648

XX2RW, ,

NOMESCO Finland

6.7

19.1

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

5.2

19.1

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

3.7

19.1

169

UKC02

NOMESCO Finland

Cystoscopy

1.6

19.0

480

3149

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

3.0

18.9

275

GD6AD

NOMESCO Finland

CT of chest and neck

14.9

18.9

1CX01, ,

NOMESCO Finland

34.5

18.9

ZX100

NOMESCO Finland

Oral

4.0

18.8

130

L02BB04

ATC

enzalutamide; oral

+∞

18.8

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

18.8

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

18.8

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

18.8

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

18.8

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

18.8

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

18.8

TJF80

NOMESCO Finland

Ostomy education

8.1

18.8

Z52.89

ICD-10 Finland

Donor of other organ or tissue

70.3

18.7

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.7

18.7

162

N02AA01

ATC

morphine; systemic, rectal

4.0

18.7

135

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

18.4

498

3317

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

18.4

295

1713

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.8

18.3

319

S77

ICPC

Malignant neoplasm of skin

25.2

18.2

120

Kela drug reimbursment

Hypogammaglobulinaemia

21.8

18.2

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

5.0

18.1

L02BG03

ATC

anastrozole; oral

52.8

17.9

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

5.1

17.9

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

18.1

17.8

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

18.1

17.8

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

22.9

17.7

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

17.7

2015A

ICD-9 Finland

Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, CELLULAR PHASE]

+∞

17.7

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

17.7

9702/3-C77.8

ICD-O-3

Mature T-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

17.7

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

17.7

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

17.7

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

17.7

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

95.6

17.6

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

95.6

17.6

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

95.6

17.6

1518, ,

Kela drug reimbursment

180.9

17.5

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

17.5

1015

7877

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

7.1

17.4

JFB30

NOMESCO Finland

Right hemicolectomy

6.0

17.3

ZX121

NOMESCO Finland

Central venous catheter

24.1

17.3

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

18.7

17.3

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

13.9

17.3

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.1

17.0

113

N03AX16

ATC

[U] pregabalin

1.5

17.0

673

4861

L04AD01

ATC

ciclosporin; systemic

3.3

16.9

193

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.5

16.9

104

420

C84.43

ICD-10 Finland

Peripheral T-cell lymphoma, large cell type

+∞

16.7

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

16.7

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

+∞

16.7

PJD99

NOMESCO Finland

Excision of other lymph nodes

+∞

16.7

372

Kela drug reimbursment

Idelalisib

+∞

16.7

C80.9

ICD-10 Finland

Malignant neoplasm, primary site unspecified

+∞

16.7

WX892

NOMESCO Finland

Monitored bed care

1.8

16.6

237

1328

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

90.5

16.6

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

170.8

16.5

L02AE04

ATC

triptorelin; parenteral

170.8

16.5

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

13.4

16.4

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

16.4

570

4006

Z51.88

ICD-10 Finland

Other specified medical care

3.0

16.4

249

9101

FHL

Bone biopsy

20.1

16.4

ZXC15

NOMESCO Finland

Use of photodynamic technique

4.8

16.1

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

16.1

679

4960

WZC15, ,

NOMESCO Finland

24.6

16.0

XKD00

NOMESCO Finland

Uroflowmetry

1.6

15.9

454

3056

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.2

15.8

130

598

ZX114

NOMESCO Finland

Intramuscular

4.0

15.7

111

TNE20

NOMESCO Finland

Bone marrow aspiration, pelvis

15.7

WVA20

NOMESCO Finland

Medicine administration

2.8

15.6

289

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

15.6

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

15.6

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

15.6

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

15.6

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

15.6

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

15.6

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

15.6

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

+∞

15.6

9659/3-C77.0

ICD-O-3

Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of head, face and neck

+∞

15.6

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

15.6

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

85.5

15.6

B73

ICPC

Leukaemia

85.5

15.6

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

160.7

15.5

C20

ICD-10 Finland

Malignant neoplasm of rectum

160.7

15.5

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

13.8

15.5

J02AC01

ATC

fluconazole; systemic

1.4

15.5

987

7750

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

15.5

146

709

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

15.4

1230

10010

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

3.0

15.2

217

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

45.2

15.1

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

3.8

14.9

120

H03AA01

ATC

levothyroxine sodium; systemic

1.4

14.8

642

4704

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

5.2

14.8

L04AA01

ATC

[U] ciclosporin

3.5

14.7

140

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

4.1

14.7

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.9

14.7

108

ELB30

NOMESCO Finland

Excision of submandibular gland

5.3

14.6

A05AA02

ATC

ursodeoxycholic acid; oral

3.2

14.6

175

9690/3-C77.2

ICD-O-3

Follicular lymphoma, NOS, of intra-abdominal lymph nodes

+∞

14.6

9651/3-C77.0

ICD-O-3

Hodgkin lymphoma, lymphocyte-rich of lymph nodes of head, face and neck

+∞

14.6

C83.51

ICD-10 Finland

B-lymphoblastic lymphoma or leukemia

+∞

14.6

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

14.6

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

14.6

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

14.6

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

14.6

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

14.6

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

14.6

196

1078

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

150.6

14.5

XW4CT

NOMESCO Finland

Biopsy of other inner organ with CT guidance

150.6

14.5

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

19.2

14.2

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

22.3

14.2

I50.1

ICD-10 Finland

Left ventricular failure

1.9

14.0

194

1076

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

14.5

14.0

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

6.7

14.0

M05BX04

ATC

denosumab; parenteral

2.1

14.0

141

702

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

13.9

381

2537

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

13.9

233

1369

104

Kela drug reimbursment

Thyroid insufficiency

1.8

13.9

197

1102

JMA11

NOMESCO Finland

Laparoscopic total splenectomy

30.1

13.9

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

53.6

13.8

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

53.6

13.8

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.6

13.8

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

13.5

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

13.5

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

13.5

C85.0

ICD-10 Finland

Lymphosarcoma

+∞

13.5

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

13.5

8000/3-C80.9

ICD-O-3

Neoplasm, malignant of unknown primary site

+∞

13.5

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

13.5

9670/3-C77.0

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck

+∞

13.5

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

13.5

L02BX03

ATC

abiraterone; oral

+∞

13.5

8070/3-C80.9

ICD-O-3

Squamous cell carcinoma, NOS, of unknown primary site

+∞

13.5

C84.0

ICD-10 Finland

Mycosis fungoides

+∞

13.5

L01CA04

ATC

vinorelbine; systemic

+∞

13.5

L02BX02

ATC

degarelix; parenteral

+∞

13.5

C83.40

ICD-10 Finland

Immunoblast large cell lymphoma

+∞

13.5

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

13.5

WX704

NOMESCO Finland

Intubation

1.8

13.5

202

1148

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

140.5

13.5

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

13.4

454

3168

J12.8

ICD-10 Finland

Other viral pneumonia

4.0

13.3

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.1

13.3

119

566

Z10.8

ICD-10 Finland

Routine general health check-up of other defined subpopulations

2.4

13.3

357

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

3.3

13.3

150

ZXC50

NOMESCO Finland

Cryotherapy

2.7

13.2

275

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

40.2

13.1

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.2

13.0

162

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

12.9

165

892

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.5

12.9

331

TK800

NOMESCO Finland

Hemodialysis

2.6

12.9

278

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

3.4

12.9

138

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

50.2

12.8

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

12.8

144

746

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.1

12.8

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

4.1

12.8

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.6

12.8

285

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

12.8

180

1005

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

10.5

12.7

EP3AT

NOMESCO Finland

Neck soft tissue biopsy with ultrasound guidance

70.1

12.6

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

70.1

12.6

C91.7

ICD-10 Finland

Other lymphoid leukaemia

+∞

12.5

C83.59

ICD-10 Finland

Lymphoblastic lymphoma of indeterminate type

+∞

12.5

9695/3-C77.0

ICD-O-3

Follicular lymphoma, grade 1 of lymph nodes of head, face and neck

+∞

12.5

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

12.5

20013

ICD-8 Finland

Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco alio (lymphonodis intrathoracalibus et intra-abdominalibus inclusis)

+∞

12.5

9650/3-C77.8

ICD-O-3

Hodgkin lymphoma, NOS, of lymph nodes of multiple regions

+∞

12.5

9590/3-C77.9

ICD-O-3

Malignant lymphoma, NOS, of lymph node, NOS

+∞

12.5

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

12.5

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

+∞

12.5

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

12.5

I89.9

ICD-10 Finland

Noninfective disorder of lymphatic vessels and lymph nodes, unspecified

17.4

12.5

ZZA50

NOMESCO Finland

Full thickness skin graft

17.4

12.5

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

24.4

12.5

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

12.4

480

3433

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

130.5

12.4

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

11.6

12.3

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

9.0

12.2

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

15.9

12.1

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

26.8

12.0

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

12.0

1057

8648

B74

ICPC

Malignant neoplasm blood other

21.3

12.0

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.3

11.9

375

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

4.0

11.9

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.7

11.9

243

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

5.9

11.8

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

11.8

154

840

ENA10

NOMESCO Finland

Biopsy of pharynx

10.5

11.7

L02AE03

ATC

goserelin; implant

8.9

11.7

L04AA06

ATC

mycophenolic acid; systemic

2.8

11.7

200

JDB10

NOMESCO Finland

Percutaneous gastrostomy

4.0

11.6

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.1

11.6

107

516

5701

FHL

Local exploration of lymph nodes (includes biopsy)

65.2

11.6

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

11.6

144

773

EMA10

NOMESCO Finland

Biopsy of tonsil

9.3

11.5

SPAT1088

SPAT

Blood transfusion

5.7

11.5

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

11.5

C84.41

ICD-10 Finland

Peripheral T-cell lymphoma, medium-sized cell type

+∞

11.5

9698/3-C77.0

ICD-O-3

Follicular lymphoma, grade 3 of lymph nodes of head, face and neck

+∞

11.5

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

11.5

9680/3-C42.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bone marrow

+∞

11.5

PJ002

NOMESCO Finland

Radical radiotherapy of neck, clavicle and axilla

+∞

11.5

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

11.5

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

11.5

9691/3-C77.4

ICD-O-3

Follicular lymphoma, grade 2 of lymph nodes of inguinal region or leg

+∞

11.5

9687/3-C77.9

ICD-O-3

Burkitt lymphoma, NOS, of lymph node, NOS

+∞

11.5

C83.5

ICD-10 Finland

Lymphoblastic (diffuse) lymphoma

+∞

11.5

1523, ,

Kela drug reimbursment

+∞

11.5

L01XX47

ATC

[U] idelalisib

+∞

11.5

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

11.5

C83.6

ICD-10 Finland

Undifferentiated (diffuse) non-Hodgkin's lymphoma

+∞

11.5

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

+∞

11.5

9695/3-C77.4

ICD-O-3

Follicular lymphoma, grade 1 of lymph nodes of inguinal region or leg

+∞

11.5

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

11.5

C83.70

ICD-10 Finland

Non-Hodgkin's lymphoma of the Burkitt type

+∞

11.5

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

+∞

11.5

3054, ,

Kela drug reimbursment

+∞

11.5

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

120.4

11.4

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

120.4

11.4

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

2.1

11.4

100

473

R11

ICD-10 Finland

Nausea and vomiting

1.7

11.3

226

1394

R84

ICPC

Malignant neoplasm bronchus/lung

35.1

11.3

R59

ICD-10 Finland

Enlarged lymph nodes

35.1

11.3

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

9.6

11.2

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

4.9

11.2

6753

FHL

Transabdominal splenectomy

17.1

11.2

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

4.7

11.2

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

3.6

11.2

101

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.2

11.1

131

KA3EB

NOMESCO Finland

Antegrade pyelography

8.0

11.1

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

5.3

11.1

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

11.1

375

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.7

11.0

212

R18

ICD-10 Finland

Ascites

2.9

11.0

168

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.4

11.0

295

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.8

10.9

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

43.4

10.9

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

3.1

10.9

143

C10AA07

ATC

rosuvastatin; oral

0.7

10.7

638

8130

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

28.1

10.7

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

17.9

10.7

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

10.7

535

4004

EL4AT

NOMESCO Finland

Salivary gland cytology with ultrasound guidance

5.6

10.7

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.4

10.6

300

J94.9

ICD-10 Finland

Pleural condition, unspecified

5.3

10.6

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.6

10.5

235

J01FF01

ATC

clindamycin; systemic

1.3

10.5

749

5930

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

10.5

338

2331

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

110.4

10.4

JN4DG

NOMESCO Finland

Body very extensive MRI with high intensity magnet

+∞

10.4

C83.52

ICD-10 Finland

T-lymphoblastic lymphoma or leukemia

+∞

10.4

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

10.4

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

10.4

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

+∞

10.4

C779, 9715, 3

ICD-O-3

+∞

10.4

1XC12, ,

NOMESCO Finland

+∞

10.4

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

10.4

9670/3-C77.8

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of multiple regions

+∞

10.4

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

10.4

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

10.4

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

+∞

10.4

9705/3-C77.8

ICD-O-3

Angioimmunoblastic T-cell lymphoma of lymph nodes of multiple regions

+∞

10.4

D76.1

ICD-10 Finland

Haemophagocytic lymphohistiocytosis

+∞

10.4

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

10.4

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

10.4

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

+∞

10.4

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

10.4

9688/3-C77.9

ICD-O-3

T-cell/histiocyte rich large B-cell lymphoma of lymph node, NOS

+∞

10.4

A02BC05

ATC

esomeprazole; systemic

1.3

10.4

1154

9696

Z31.8

ICD-10 Finland

Other procreative management

32.6

10.3

TQW20

NOMESCO Finland

Tatoe

32.6

10.3

B03XA01

ATC

erythropoietin; parenteral

3.9

10.3

A02BA02

ATC

ranitidine; systemic

1.4

10.3

562

4267

D11.70

ICD-10 Finland

Gland sublingual

8.8

10.3

6BA02, ,

NOMESCO Finland

9.6

10.2

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

10.2

306

2078

A03

ICPC

Fever

1.5

10.2

391

2790

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

10.1

528

3977

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

10.1

379

2692

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

11.3

10.0

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

8.4

10.0

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

40.2

10.0

R06.0

ICD-10 Finland

Dyspnoea

1.3

10.0

784

6288

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

16.7

9.9

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.8

9.8

168

WX702

NOMESCO Finland

Supraglottic ventilation device

1.8

9.8

135

749

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

20.1

9.8

DHB00

NOMESCO Finland

Excision of lesion of external nose

8.7

9.8

J01MA01

ATC

ofloxacin; systemic

1.6

9.8

239

1551

B04

ICPC

Blood symptom/complaint

4.7

9.8

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

55.1

9.6

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

55.1

9.6

DAB10

NOMESCO Finland

Partial excision of auricle

55.1

9.6

D77

ICPC

Malignant digestive neopl other/NOS

55.1

9.6

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

55.1

9.6

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

9.6

331

2311

QBA10

NOMESCO Finland

Incision of skin of trunk

3.5

9.6

4704

FHL

Neck tumor removal

11.4

9.5

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

4.6

9.5

E0000UV, ,

ATC

1.3

9.5

1125

9504

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

9.5

142

809

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

9.4

267

1790

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

100.3

9.4

E89.4

ICD-10 Finland

Postprocedural ovarian failure

100.3

9.4

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.6

9.4

206

1302

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

9.4

724

5783

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

30.1

9.4

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

9.4

127

702

C85

ICD-10 Finland

Other and unspecified types of non-Hodgkin lymphoma

+∞

9.4

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

+∞

9.4

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

9.4

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

9.4

C83.7

ICD-10 Finland

Burkitt lymphoma

+∞

9.4

JN6CD

NOMESCO Finland

Very extensive CT of torso and neck

+∞

9.4

189

Kela drug reimbursment

Imatinib

+∞

9.4

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

+∞

9.4

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

9.4

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

9.4

WX1DG

NOMESCO Finland

Very extensive total body MRI with high intensity magnet

+∞

9.4

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

9.4

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

9.4

9690/3-C77.3

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of axilla or arm

+∞

9.4

C16.00

ICD-10 Finland

Cardia

+∞

9.4

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

9.4

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

9.4

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

9.4

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

9.4

394

Kela drug reimbursment

Palbociclib

+∞

9.4

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

+∞

9.4

1501

Kela drug reimbursment

Palbociclib

+∞

9.4

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.3

9.4

311

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.4

9.4

255

B59

ICD-10 Finland

Pneumocystosis

21.7

9.3

G53.0

ICD-10 Finland

Postzoster neuralgia

4.0

9.3

R93.8

ICD-10 Finland

Abnormal findings on diagnostic imaging of other specified body structures

4.9

9.3

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.9

9.3

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

6.9

9.3

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

9.3

157

927

L04.9

ICD-10 Finland

Acute lymphadenitis, unspecified

8.7

9.3

XQ848

NOMESCO Finland

Dermatological photography

2.2

9.1

321

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

9.1

150

879

6101

FHL

Exploratory laparotomy, includes possible biopases

5.0

9.1

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

4.8

9.1

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

4.6

9.1

B29

ICPC

Lymph/immune mech sympt/complt other

8.3

9.1

Z3226

NOMESCO Finland

Physiotherapist

1.4

9.0

472

3556

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

9.0

113

611

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

2.1

8.9

423

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

18.6

8.9

N06DX01

ATC

memantine; oral

0.5

8.9

1764

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

7.4

8.9

L03AA04, ,

ATC

24.1

8.9

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

24.1

8.9

KAD00

NOMESCO Finland

Partial nephrectomy

12.5

8.9

R05

ICD-10 Finland

Cough

1.3

8.9

595

4657

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

4.7

8.8

RS220, ,

NOMESCO Finland

3.0

8.8

129

R93.5

ICD-10 Finland

Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum

3.0

8.7

124

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

50.1

8.7

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

50.1

8.7

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

8.6

120

670

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

4.4

8.6

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

8.6

265

1810

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

8.6

121

678

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.0

8.6

120

UDQ02

NOMESCO Finland

Direct laryngoscopy

3.6

8.5

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.1

8.5

115

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.8

8.5

123

694

ZXF10

NOMESCO Finland

Interruption caused by technical failure of equipment

27.6

8.5

R60.0

ICD-10 Finland

Localized oedema

1.4

8.5

336

2411

KEB00

NOMESCO Finland

Biopsy of prostate

4.2

8.4

Z92.6

ICD-10 Finland

Personal history of chemotherapy for neoplastic disease

90.3

8.4

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

90.3

8.4

JL2AT

NOMESCO Finland

Cytology of pancreas with ultrasound guidance

90.3

8.4

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

90.3

8.4

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

90.3

8.4

A26

ICPC

Fear of cancer, NOS

4.9

8.4

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

8.3

9691/3-C77.2

ICD-O-3

Follicular lymphoma, grade 2 of intra-abdominal lymph nodes

+∞

8.3

8130/3-C67.9

ICD-O-3

Papillary urothelial carcinoma of bladder, NOS

+∞

8.3

9659/3-C77.4

ICD-O-3

Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of inguinal region or leg

+∞

8.3

C83.4

ICD-10 Finland

Immunoblastic (diffuse) non-Hodgkin's lymphoma

+∞

8.3

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

8.3

9651/3-C77.8

ICD-O-3

Hodgkin lymphoma, lymphocyte-rich of lymph nodes of multiple regions

+∞

8.3

ZX131

NOMESCO Finland

Intrathecal

+∞

8.3

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

+∞

8.3

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

+∞

8.3

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

8.3

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

+∞

8.3

9823/3-C77.0

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of head, face and neck

+∞

8.3

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

8.3

L01XE01

ATC

[U] imatinib

+∞

8.3

2002A

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Burkitt's tumour or lymphoma

+∞

8.3

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

8.3

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

8.3

9688/3-C77.8

ICD-O-3

T-cell/histiocyte rich large B-cell lymphoma of lymph nodes of multiple regions

+∞

8.3

XX1XN

NOMESCO Finland

Other isotope examination

+∞

8.3

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

+∞

8.3

9650/3-C77.3

ICD-O-3

Hodgkin lymphoma, NOS, of lymph nodes of axilla or arm

+∞

8.3

1DB01, ,

NOMESCO Finland

+∞

8.3

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

8.3

C83.41

ICD-10 Finland

Immunoblastic (diffuse)

+∞

8.3

1CD02, ,

NOMESCO Finland

+∞

8.3

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.3

8.3

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

8.3

211

1381

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.1

8.3

381

Z29.9

ICD-10 Finland

Prophylactic measure, unspecified

3.5

8.2

R22.7

ICD-10 Finland

Localized swelling, mass and lump, multiple sites

14.5

8.2

I50.0

ICD-10 Finland

Congestive heart failure

1.5

8.2

247

1681

EP1BG

NOMESCO Finland

MRI examination of soft tissue of neck with high intesity magnet

7.5

8.1

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

4.4

8.1

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

4.5

8.1

B99

ICPC

Blood/lymph/spleen disease other

4.5

8.1

A21

ICPC

Risk factor for malignancy

33.4

8.1

J94.0

ICD-10 Finland

Chylous effusion

33.4

8.1

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

33.4

8.1

KAC10

NOMESCO Finland

Total nephrectomy with capsule

17.2

8.1

7842A

ICD-9 Finland

Symptoms involving head and neck, Swelling, mass, or lump in head and neck

11.7

8.1

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

3.2

8.1

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

6.8

8.1

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

8.0

194

1256

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.7

8.0

147

T80.8

ICD-10 Finland

Other complications following infusion, transfusion and therapeutic injection

22.1

8.0

TGA30

NOMESCO Finland

Thoracocentesis

3.9

8.0

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.9

7.9

126

ELB40

NOMESCO Finland

Partial parotidectomy

2.9

7.9

126

RS222, ,

NOMESCO Finland

2.9

7.9

126

B34.9

ICD-10 Finland

Viral infection, unspecified

2.1

7.9

335

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.5

7.8

178

WX882

NOMESCO Finland

High dependency care

2.1

7.8

357

JCW98

NOMESCO Finland

Other transluminal endoscopic procedure on oesophagus

45.1

7.7

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

45.1

7.7

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

2.4

7.7

216

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

7.4

7.7

D11AH01

ATC

tacrolimus; topical

3.4

7.7

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.4

7.7

198

R31

ICD-10 Finland

Unspecified haematuria

1.5

7.5

263

1842

ELB00

NOMESCO Finland

Excision or exploration of lesion of salivary gland

10.0

7.5

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

2.6

7.5

158

UDC00

NOMESCO Finland

Ear microscopy

1.5

7.5

195

1285

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

7.5

276

SPAT1255

SPAT

Intravenous administration of medicine

1.6

7.5

183

1190

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

7.4

445

3418

PJD91

NOMESCO Finland

Excision of lymph nodes in neck, 1 to 2 areas in total

80.3

7.4

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

80.3

7.4

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

80.3

7.4

9109

FHL

Other measure in this category

7.6

7.4

SAA04

NOMESCO Finland

Special examination of mouth

1.7

7.4

130

779

WX720

NOMESCO Finland

Own respiration

1.7

7.3

126

749

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

7.3

148

919

WPA13

NOMESCO Finland

Palliative consultation

8.4

7.3

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.5

7.3

1354

JM2AT

NOMESCO Finland

Biopsy of spleen with ultrasound guidance

+∞

7.3

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

7.3

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

+∞

7.3

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

+∞

7.3

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

7.3

C03.1

ICD-10 Finland

Malignant neoplasm: Lower gum

+∞

7.3

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

7.3

C44.02

ICD-10 Finland

Spinocellular carcinoma of the lip skin

+∞

7.3

9695/3-C77.2

ICD-O-3

Follicular lymphoma, grade 1 of intra-abdominal lymph nodes

+∞

7.3

L02BA03

ATC

fulvestrant; parenteral

+∞

7.3

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

7.3

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

+∞

7.3

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

+∞

7.3

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

7.3

9670/3-C77.3

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of axilla or arm

+∞

7.3

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

7.3

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

7.3

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

7.3

PJ003

NOMESCO Finland

Adjuvant radiotherapy of neck, clavicle and axilla

+∞

7.3

C38.1

ICD-10 Finland

Malignant neoplasm: Anterior mediastinum

+∞

7.3

L01EM01

ATC

idelalisib; oral

+∞

7.3

C90.2

ICD-10 Finland

Extramedullary plasmacytoma

+∞

7.3

9670/3-C77.4

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of inguinal region or leg

+∞

7.3

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

7.3

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

7.3

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

7.3

PJ023

NOMESCO Finland

Adjuvant radiotherapy of mediastinal lymphnodes

+∞

7.3

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

7.3

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

7.3

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

7.3

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

+∞

7.3

YX9AW, ,

NOMESCO Finland

+∞

7.3

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.6

7.3

149

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.1

7.3

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

15.8

7.2

GDB10

NOMESCO Finland

Wedge resection of lung

15.8

7.2

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

15.8

7.2

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

4.3

7.2

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

4.3

7.2

I88.8

ICD-10 Finland

Other nonspecific lymphadenitis

7.3

7.2

A02BX02

ATC

sucralfate; oral

1.7

7.2

113

656

JDE00

NOMESCO Finland

Gastrojejunostomy

30.1

7.1

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

30.1

7.1

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

30.1

7.1

J02AC04

ATC

posaconazole; systemic

30.1

7.1

D47.7

ICD-10 Finland

Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue

20.1

7.1

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

7.1

180

1179

UJC01

NOMESCO Finland

Scopy of lower throat

3.2

7.1

ZZR10

NOMESCO Finland

Flap of skin and muscle

7.9

7.1

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.2

7.1

269

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

7.1

441

3407

BA2AT

NOMESCO Finland

Biopsy of thyroid with ultrasound quidance

12.0

7.1

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

7.0

1173

10219

D06BB10

ATC

imiquimod; topical

1.7

7.0

113

661

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.4

7.0

D46.7

ICD-10 Finland

Other myelodysplastic syndromes

4.4

7.0

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

6.9

1138

9895

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.5

6.9

171

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

13.8

6.9

JG1BG

NOMESCO Finland

MRI of rectum

13.8

6.9

WPB10

NOMESCO Finland

Making a convalescent care decision

13.8

6.9

S29

ICPC

Skin symptom/complaint other

1.3

6.8

490

3864

S21

ICPC

Skin texture symptom/complaint

1.4

6.8

359

2704

A46

ICD-10 Finland

Erysipelas

1.3

6.8

416

3205

EMB10

NOMESCO Finland

Tonsillectomy

1.8

6.8

104

599

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

2.6

6.8

149

GD2AT

NOMESCO Finland

Cytology of the lungs with ultrasound guidance

40.1

6.8

N06DA03

ATC

rivastigmine; oral, transdermal

0.4

6.7

907

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

4.3

6.7

DAB00

NOMESCO Finland

Excision of lesion of auricle

3.6

6.7

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.4

6.7

837

D36.0

ICD-10 Finland

Benign neoplasm: Lymph nodes

16.7

6.7

N63

ICD-10 Finland

Unspecified lump in breast

1.8

6.7

103

594

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

3.9

6.7

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

7.2

6.7

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

22.6

6.7

RS221, ,

NOMESCO Finland

2.5

6.7

162

JJA20

NOMESCO Finland

Open biopsy of liver

7.8

6.6

C07AB07

ATC

bisoprolol; oral

1.2

6.6

1516

13601

J01FA06

ATC

roxithromycin; oral

1.2

6.6

1080

9376

ZXD20

NOMESCO Finland

Day surgery

1.4

6.6

317

2353

D75

ICPC

Malignant neoplasm colon/rectum

12.3

6.6

ZZA00

NOMESCO Finland

Split skin graft

2.1

6.5

305

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

10.0

6.5

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.8

6.5

555

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

6.5

320

2384

K11.2

ICD-10 Finland

Sialoadenitis

1.8

6.5

460

P01AB01

ATC

metronidazole; oral, rectal

1.2

6.5

1011

8730

WW200, ,

SPAT

0.8

6.5

425

5387

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

3.1

6.5

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.2

6.4

221

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

5.7

6.4

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

3.5

6.4

JN5AP

NOMESCO Finland

Total body PET (1 picture)

70.0

6.4

E28.8

ICD-10 Finland

Other ovarian dysfunction

70.0

6.4

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

70.0

6.4

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

70.0

6.4

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

70.0

6.4

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

6.4

158

1030

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.3

6.4

190

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.0

6.4

349

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

14.3

6.4

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.0

6.4

322

D07AB08

ATC

desonide; topical

1.4

6.4

267

1937

JF1BD

NOMESCO Finland

Very extensive small bowel CT

4.1

6.3

TQW80

NOMESCO Finland

Local dermatologic skincare

2.0

6.3

357

J35.1

ICD-10 Finland

Hypertrophy of tonsils

2.5

6.3

148

NK6BN

NOMESCO Finland

Bone dynamic isotope examination

5.9

6.3

L03.3

ICD-10 Finland

Cellulitis of trunk

3.2

6.3

G04BE03

ATC

sildenafil; oral

3.5

6.3

CBA10

NOMESCO Finland

Biopsy of eyelid

3.3

6.3

B44.0

ICD-10 Finland

Invasive pulmonary aspergillosis

18.0

6.3

WPA44

NOMESCO Finland

Nursing home for palliative care

18.0

6.3

1CA02, ,

NOMESCO Finland

+∞

6.3

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

6.3

8140/3-C23.9

ICD-O-3

Adenocarcinoma, NOS, of gallbladder

+∞

6.3

V03AB28, ,

ATC

+∞

6.3

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

6.3

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

+∞

6.3

X77

ICPC

Malignant neopl genital female other

+∞

6.3

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

6.3

9698/3-C77.4

ICD-O-3

Follicular lymphoma, grade 3 of lymph nodes of inguinal region or leg

+∞

6.3

9673/3-C77.4

ICD-O-3

Mantle cell lymphoma of lymph nodes of inguinal region or leg

+∞

6.3

2017X

ICD-9 Finland

Hodgkin's disease, Lymphocytic depletion[MORBUS HODGKIN, LYMPHOCYTIC DEPLETION NUD]

+∞

6.3

20228

ICD-8 Finland

Other neoplasms of lymphoid tissue, Other primary malignant neoplasms of lymphoid tissue

+∞

6.3

9651/3-C77.3

ICD-O-3

Hodgkin lymphoma, lymphocyte-rich of lymph nodes of axilla or arm

+∞

6.3

8070/3-C00.1

ICD-O-3

Squamous cell carcinoma, NOS, of external lower lip

+∞

6.3

L01BC59

ATC

trifluridine, combinations; systemic

+∞

6.3

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

6.3

C49.20

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology

+∞

6.3

1XC0R, ,

NOMESCO Finland

+∞

6.3

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

6.3

20018

ICD-8 Finland

Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco non indicato sive generalisatum

+∞

6.3

3AF07, ,

NOMESCO Finland

+∞

6.3

2014X

ICD-9 Finland

Hodgkin's disease, Lymphocytic-histiocytic predominance[MORBUS HODGKIN,LYMPHOCYTIC PREDOMINANCE"""",NUD]

+∞

6.3

J70.1

ICD-10 Finland

Chronic and other pulmonary manifestations due to radiation

+∞

6.3

8070/3-C44.5

ICD-O-3

Squamous cell carcinoma, NOS, of skin of trunk

+∞

6.3

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

6.3

9714/3-C77.8

ICD-O-3

Anaplastic large cell lymphoma, T-cell and Null-cell type of lymph nodes of multiple regions

+∞

6.3

WE100

NOMESCO Finland

Profylactic cytostatic therapy

+∞

6.3

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

6.3

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

6.3

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

6.3

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

6.3

UJC20

NOMESCO Finland

Extensive endoscopy to identify diagnosed or suspected primary malignant neoplasm of head or neck

+∞

6.3

JM1AT

NOMESCO Finland

Cytology of spleen with ultrasound guidance

+∞

6.3

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

6.3

9691/3-C77.3

ICD-O-3

Follicular lymphoma, grade 2 of lymph nodes of axilla or arm

+∞

6.3

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

6.3

1BC01, ,

NOMESCO Finland

+∞

6.3

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

6.3

L01XB01

ATC

procarbazine; oral

+∞

6.3

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

+∞

6.3

L01EF01

ATC

palbociclib; oral

+∞

6.3

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

6.3

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

6.3

C38.3

ICD-10 Finland

Malignant neoplasm: Mediastinum, part unspecified

+∞

6.3

4CJ01, ,

NOMESCO Finland

+∞

6.3

9680/3-C80.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of unknown primary site

+∞

6.3

316

Kela drug reimbursment

Imatinib

+∞

6.3

5609

FHL

Other measure in this category

+∞

6.3

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

6.3

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

6.3

L01EA01

ATC

imatinib; oral

+∞

6.3

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

+∞

6.3

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

+∞

6.3

9673/3-C77.0

ICD-O-3

Mantle cell lymphoma of lymph nodes of head, face and neck

+∞

6.3

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

6.3

GA2AT

NOMESCO Finland

Pleural biopsy with ultrasound guidance

26.7

6.2

K02.9

ICD-10 Finland

Dental caries, unspecified

2.3

6.2

199

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

7.0

6.2

B07.9

ICD-10 Finland

Verruca simplex

1.9

6.2

431

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.1

6.2

GBB00

NOMESCO Finland

Tracheostomy

2.7

6.2

115

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

5.3

6.1

0388X

ICD-9 Finland

Septicaemia, Other specified septicaemias

7.7

6.1

C09AA05

ATC

ramipril; oral

1.2

6.1

772

6517

ZX050

NOMESCO Finland

Stereotactic radiotherapy

12.5

6.1

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

12.5

6.1

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

8.6

6.0

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

8.6

6.0

KC1GB

NOMESCO Finland

Cystography with X-ray

8.6

6.0

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

6.7

6.0

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

6.0

697

5826

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

6.0

184

1258

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

185

51.40

321.35

2.2

2.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1022

3000

4.43

316.14

3.5

2.2

1.74

1.76

0.23

952

2622

(3001604) Monocytes [#/volume] in Blood

2718

12885

6.30

307.65

9.8

5.5

0.62

0.60

e9/l

2.51

2493

11077

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

427

453

10.62

307.65

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1536

2460

10.48

307.65

1.5

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2192

2514

22.31

307.65

7.7

2.9

258.03

234.51

u/l

7.81

2133

2338

(3017181) Myelocytes/100 leukocytes in Blood

834

2010

5.16

307.65

5.9

3.9

1.07

0.80

1.81

582

507

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1584

2989

8.97

307.65

1.5

1.6

—

(40768795) Lymph node Pathology biopsy report

974

315.69

307.65

1.5

1.1

—

(3002030) Lymphocytes/100 leukocytes in Blood

2634

12347

5.85

307.65

10.7

5.8

26.56

27.64

3.90

2567

11457

(1175426) CD3 cells/100 lymphocytes in Blood

378

110

38.49

307.65

2.3

1.8

73.08

73.19

0.03

361

102

(46235355) HIV 1 and 2 tests - Meaningful Use set

1674

3679

7.92

307.65

1.6

1.8

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1228

3756

4.53

307.65

6.5

2.7

0.81

0.82

mmol/l

6.52

1196

3460

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

375

102

41.14

307.65

2.3

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2662

11960

6.44

307.65

12.1

5.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

511

358

16.59

307.65

5.1

5.7

388.51

542.86

iu/ml

0.41

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

386

331

13.01

307.65

1.3

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2329

10774

4.60

307.65

8.1

3.9

34.41

35.72

g/l

21.39

2256

9835

(3005719) IgG [Mass/volume] in Serum or Plasma

1042

1739

8.16

307.65

3.8

2.2

8.74

10.76

g/l

31.31

1001

1577

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1410

1495

15.30

307.65

1.4

—

(3006504) Eosinophils/100 leukocytes in Blood

2622

11975

6.02

307.65

10.4

5.7

2.74

2.97

5.72

2554

11055

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

602

251.45

307.65

1.4

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2831

14241

6.60

307.65

23.7

6.4

3.60

4.28

e9/l

52.41

2637

12201

(3013115) Eosinophils [#/volume] in Blood

2742

13391

6.18

307.65

10.6

5.6

0.18

0.20

e9/l

11.76

2529

11660

(3042111) Morphology [Interpretation] in Bone marrow Narrative

568

315

21.40

307.65

1.5

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

385

397

10.79

307.65

1.4

1.5

113.85

110.71

u/ml

0.14

101

(3045142) Bone marrow Pathology biopsy report

606

169

43.32

307.65

1.5

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

265

30.14

307.65

3.6

2.3

33.80

45.33

6.36

188

(4035726) Immunohistochemistry procedure

1295

704

28.91

307.65

1.7

1.3

—

(3011412) CD3 cells [#/volume] in Blood

474

147

37.24

307.65

2.6

1.9

1.03

1.16

e9/l

0.99

431

131

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

489

264

21.43

307.65

2.7

2.9

9048.13

358.63

u/ml

1.14

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

302

117

28.20

307.65

2.8

1.8

555.23

440.27

e6/l

1.52

253

100

(3006315) Basophils [#/volume] in Blood

2720

12933

6.29

307.65

9.8

5.5

0.04

e9/l

5.38

2495

11116

(3026493) Urate [Moles/volume] in Serum or Plasma

1952

7301

4.87

307.65

5.6

2.5

1537.10

5699.57

umol/l

7.12

1893

6286

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2685

12577

6.19

307.65

15.0

3.8

10.48

11.98

umol/l

7.04

2646

11741

(40765096) Chromosome analysis panel by Banding

286

107.48

307.65

1.2

1.1

—

(3022096) Basophils/100 leukocytes in Blood

2595

11606

6.04

307.65

10.1

5.7

0.68

0.20

2523

10698

(3028026) IgM [Mass/volume] in Serum or Plasma

738

1376

6.56

307.65

2.8

1.4

1.17

1.18

g/l

0.03

692

1246

(21494814) CD8 cells/100 lymphocytes in Specimen

200

44.18

307.65

2.2

2.0

—

(3018010) Neutrophils/100 leukocytes in Blood

2607

12235

5.68

307.65

9.8

5.6

56.90

57.46

1.28

2539

11345

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

297

111

29.19

307.65

2.9

1.8

0.22

0.23

e9/l

0.10

256

(3019069) Monocytes/100 leukocytes in Blood

2628

12043

6.02

307.65

10.9

6.0

9.48

8.74

22.45

2559

11135

(3019198) Lymphocytes [#/volume] in Blood

2732

13255

6.17

307.65

9.9

5.5

2.01

1.86

e9/l

0.99

2537

11616

(3023368) Bacteria identified in Blood by Culture

1642

6888

3.65

300.01

7.7

3.9

—

(3004809) Band form neutrophils/100 leukocytes in Blood

317

300

11.54

295.23

4.2

3.0

1.74

1.28

1.02

300

252

(3023520) Reticulocytes [#/volume] in Blood

839

2250

4.61

289.74

3.6

2.2

68.94

68.80

e9/l

0.04

688

1706

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

382

487

8.70

284.84

2.3

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

399

541

8.21

282.56

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

386

505

8.48

281.68

2.2

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

760

1942

4.74

278.19

5.9

3.9

0.16

0.05

4.50

505

438

(3002179) Metamyelocytes/100 leukocytes in Blood

738

1859

4.78

274.77

5.6

3.7

0.72

0.63

0.52

488

451

(3006245) CD3-CD19+ cells/100 cells in Blood

179

30.90

272.12

2.3

1.9

8.65

9.50

0.25

158

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

591

1243

5.53

272.04

2.8

1.5

14.96

2.70

ug/l

2.61

455

914

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

317

358

9.65

259.63

2.3

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

152

38.74

247.16

3.1

1.6

45.05

53.98

u/l

0.09

147

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2316

13026

3.39

245.98

10.6

5.8

1.22

1.21

mmol/l

7.32

1953

11060

(3015377) Calcium [Moles/volume] in Serum or Plasma

1710

8136

3.19

240.94

7.3

2.1

2.36

2.35

mmol/l

1.03

1597

6809

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

334

442

8.26

240.65

1.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2136

11734

3.17

230.47

9.0

5.4

1.22

1.21

mmol/l

7.92

2065

10454

(3025159) Blasts/100 leukocytes in Blood

677

1860

4.29

222.30

5.8

4.0

0.11

0.07

0.35

416

362

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2952

20010

4.37

219.17

19.2

5.4

84.09

75.77

u/l

15.29

2892

18490

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

306

414

8.02

215.96

1.3

281.84

262.11

u/ml

0.44

186

257

(3048929) Epstein Barr virus Ab [Presence] in Serum

383

661

6.40

215.66

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2055

11320

3.03

215.37

3.9

2.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

937

3296

3.53

214.33

7.0

5.7

1.04

mmol/l

0.03

909

3026

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

200

151

14.00

213.81

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

420

801

5.83

213.23

2.4

3.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1143

4572

3.25

211.78

5.1

2.1

2.47

2.44

mmol/l

10.75

1103

3879

(40768804) Tissue Pathology biopsy report

1645

8257

2.90

200.75

2.6

1.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1071

4252

3.21

199.26

2.7

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

651

1890

4.02

196.66

1.8

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

263

337

8.37

194.00

2.3

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

263

337

8.37

194.00

2.3

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

273

378

7.76

188.44

1.8

1.4

—

(3018418) pH of Serum or Plasma

1510

7432

2.84

188.32

7.3

3.3

7.40

0.54

384

1273

(3000060) B lymphocytes [#/volume] in Blood

122

30.81

185.81

2.2

1.7

101.67

173.46

e6/l

1.03

(3044640) Blood type and Crossmatch panel - Blood

1499

7392

2.82

185.64

4.1

2.2

—

(40758558) Short blood count panel - Blood

1299

5956

2.90

184.53

17.2

4.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

206

212

10.27

179.88

4.4

3.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

240

302

8.47

179.53

1.7

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

680

2169

3.66

177.92

2.6

1.6

64.03

66.88

g/l

12.82

652

1934

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

284

440

6.95

176.88

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

225

286

8.35

166.77

1.8

1.3

—

(3002256) Pathology report gross observation

625

1980

3.64

164.35

1.4

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

192

205

9.86

163.08

2.4

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

572

1720

3.79

162.46

2.2

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

120

22.17

162.20

3.6

1.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

189

202

9.84

160.39

2.5

2.4

—

(3021589) Normoblasts [#/volume] in Blood

1944

11480

2.60

160.23

17.0

8.4

0.00

e9/l

0.89

1648

9358

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

183

190

10.12

158.61

1.3

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

235

333

7.50

158.57

1.9

1.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2072

12683

2.60

157.22

15.6

17.8

1.26

1.34

inr

3.58

574

3605

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

124

18.88

156.20

4.3

2.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

196

228

9.06

155.91

2.4

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

221

306

7.65

152.13

1.9

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

185

208

9.34

151.05

4.3

2.8

53.66

59.48

2.32

173

166

(3013707) Erythrocyte sedimentation rate by Westergren method

2790

20039

3.08

149.68

6.8

4.1

15.34

11.88

mm/h

20.91

2685

18431

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

400

1002

4.39

145.55

2.4

1.7

1.73

1.61

ug/l

0.07

367

867

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1169

5654

2.62

142.73

3.9

2.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

761

2945

3.03

142.54

2.4

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

189

235

8.45

142.43

2.0

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

755

2941

3.01

139.50

2.4

1.7

—

(3042936) Bacteria identified in Isolate by Culture

852

3566

2.85

137.78

2.0

—

(40758292) HTLV I+II Ab panel - Serum

58.96

133.84

1.5

1.2

—

(3000012) Reticulocyte production index

212

332

6.74

130.16

2.7

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

1209

6174

2.48

129.16

5.8

3.6

88.57

86.70

1.81

1194

6007

(3007164) IgA [Mass/volume] in Serum or Plasma

1002

4689

2.60

128.87

2.3

1.3

2.04

2.55

g/l

8.99

789

2729

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

158

179

9.20

128.09

2.6

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

158

179

9.20

128.09

2.6

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

158

179

9.20

128.09

2.6

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

250

476

5.59

125.73

2.3

2.0

293.77

25.93

u/ml

2.29

193

378

(3042631) Mycobacterium sp identified in Specimen

197

313

6.62

119.18

2.2

3.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

66.23

118.26

1.8

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

102

15.43

116.41

3.0

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

17.67

113.83

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

100

15.12

112.90

3.1

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

100

15.12

112.90

3.1

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

111

12.17

110.20

2.9

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

111

12.17

110.20

2.9

1.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

14.53

109.39

1.9

2.5

4681.38

3880.82

u/ml

0.07

(3037692) Legionella sp identified in Specimen by Organism specific culture

102

13.62

108.57

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

642

2607

2.80

107.44

5.3

2.3

7.89

7.83

umol/l

0.02

587

2232

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

151

205

7.66

105.42

1.3

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2244

15852

2.20

101.16

6.9

4.4

6.64

6.81

mmol/l

3.92

2177

14750

(3037756) Immunofixation for Serum or Plasma

228

489

4.92

99.84

1.3

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

33.21

96.69

1.2

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

109

112

10.02

94.89

2.0

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

840

4103

2.39

94.49

2.9

2.0

29.62

30.04

1.13

827

3968

(3002582) Erythrocytes [#/volume] in Urine

1317

7775

2.12

92.75

3.6

3.0

28.72

60.77

e6/l

2.70

1046

5915

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

115

131

9.05

92.68

2.0

1.3

—

(3003694) ABO and Rh group [Type] in Blood

1175

6651

2.16

92.19

1.5

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

107

113

9.74

91.29

2.0

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

152

245

6.44

90.49

1.8

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

152

245

6.44

90.49

1.8

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

129

176

7.58

89.60

2.1

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

43.98

87.22

2.5

1.0

74.65

18.96

u/ml

0.78

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

367

1230

3.22

85.54

1.7

1.6

1.68

1.52

g/l

1.91

301

1055

(3030467) Casts [#/volume] in Urine by Automated count

1208

7125

2.07

83.27

3.6

2.9

0.53

0.45

e6/l

0.36

944

5372

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

245

641

4.04

83.02

3.0

2.5

3.94

3.49

g/l

3.01

237

605

(3018095) Leukocytes [#/volume] in Urine

1447

9138

2.01

82.22

4.2

3.5

117.65

104.37

e6/l

0.14

1090

6375

(36304419) Bacteria [Presence] in Urine

1173

6909

2.06

80.62

3.5

2.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

175

362

5.04

79.78

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

9.51

76.48

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

9.51

76.48

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

114

162

7.24

76.32

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

475

1967

2.64

74.70

2.3

2.1

0.19

0.21

g/l

3.05

444

1787

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1353

8567

1.96

74.30

3.7

3.1

1814.92

1527.26

ng/l

1.53

1221

7339

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

25.13

73.95

1.6

3.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

186

433

4.48

73.43

6.1

3.5

56.74

57.52

0.31

186

433

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

143

271

5.46

71.92

2.6

2.0

860.58

23.51

u/ml

0.65

123

244

(40768806) Pleura Pathology biopsy report

121

197

6.33

71.25

1.7

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

701

3536

2.23

70.79

2.3

2.7

22.22

23.14

0.79

630

2977

(3031040) Bacteria [#/volume] in Urine by Automated count

2279

17304

1.94

70.45

5.1

4.3

511.90

2046.61

e6/l

1.55

254

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

475

2028

2.56

69.91

8.3

3.0

1.23

mmol/l

1.10

461

1712

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

151

324

4.83

65.85

5.5

6.5

11.00

11.84

mg/l

1.38

137

295

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

18.19

64.66

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

235

708

3.49

64.58

1.7

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

232

699

3.49

63.74

1.6

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

719

3815

2.12

63.11

2.3

2.6

2.19

2.31

g/l

5.88

674

3502

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

303

1079

2.98

63.05

1.7

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

303

1080

2.98

62.95

1.7

1.4

7.43

7.48

g/l

0.15

285

948

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

302

1079

2.97

62.46

1.7

1.4

3.58

3.76

g/l

0.59

285

948

(3000991) Gas panel - Venous blood

475

2136

2.42

62.11

7.3

8.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

15.22

61.42

2.8

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

266

898

3.13

60.70

1.9

1.5

0.53

0.39

g/l

0.53

237

761

(3020779) Urea [Moles/volume] in Serum or Plasma

504

2357

2.33

60.18

7.8

7.4

10.14

10.62

mmol/l

0.65

487

2234

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

217

653

3.48

59.68

1.9

2.0

11.94

11.51

mg/l

0.29

205

596

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

376

1544

2.61

59.53

1.8

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

152

6.54

59.27

1.9

1.2

3.33

3.09

ug/l

0.08

135

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

244

798

3.21

58.70

1.8

1.4

0.02

g/l

0.17

232

723

(3000093) Morphology [Interpretation] in Blood Narrative

119

230

5.32

58.52

1.1

—

(3028433) Virus identified in Specimen by Culture

9.16

58.17

1.5

1.1

—

(3012441) Differential panel - Pleural fluid

115

217

5.45

58.07

1.8

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

283

1016

2.95

57.93

1.8

1.4

8.98

10.36

g/l

4.24

265

879

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

281

1008

2.95

57.60

1.8

1.4

3.26

2.94

g/l

4.48

264

878

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

245

814

3.16

57.39

3.4

0.34

u/ml

0.04

150

486

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

729

4014

2.04

57.30

3.2

2.7

1.76

2.49

e6/l

1.74

400

2163

(3022948) Iron [Moles/volume] in Serum or Plasma

745

4145

2.02

56.83

2.3

2.6

12.04

13.25

umol/l

4.05

707

3828

(3000850) Epithelial cells [#/volume] in Urine

909

5429

1.92

56.30

2.9

2.4

4.83

5.02

e6/l

0.19

839

4813

(3000494) Fungus identified in Specimen by Culture

590

3021

2.15

56.20

1.6

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

151

368

4.25

56.09

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

245

826

3.12

55.96

2.0

1.5

36.33

34.68

mg/l

0.17

197

670

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

103

182

5.80

55.79

1.4

1.3

358.41

290.33

u/l

0.50

172

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

194

571

3.54

55.16

1.4

1.3

119.25

213.53

miu/ml

2.32

245

(3034860) Kappa light chains.free [Mass/volume] in Serum

244

829

3.09

54.98

2.0

1.5

52.70

47.81

mg/l

0.46

199

678

(21494434) Karyotype in Bone marrow

102

184

5.68

54.06

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

223

730

3.20

53.50

1.8

1.4

0.00

g/l

-0.00

212

667

(3023199) Leukocytes [#/volume] in Pleural fluid

119

249

4.91

53.44

1.8

1.5

1864.34

1603.15

e6/l

0.37

175

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

117

242

4.97

53.26

1.2

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

364

1554

2.50

52.91

2.0

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

236

806

3.07

52.67

2.0

1.5

3.89

2.96

ratio

0.17

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

21.90

52.54

6.0

1.2

—

(3002032) Base excess in Venous blood by calculation

522

2613

2.18

52.40

4.8

3.6

1.99

1.97

mmol/l

0.05

451

2213

(3028308) Erythrocytes [#/volume] in Pleural fluid

111

223

5.11

52.25

1.7

1.5

34802.16

72075.48

e6/l

0.59

128

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

216

706

3.20

51.93

3.0

1.5

90.80

24.82

u/ml

3.78

209

672

(3026782) Osmolality of Urine

863

5183

1.89

51.92

3.1

2.7

543.56

548.67

mosm/kgh2o

0.29

776

4382

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

223

743

3.14

51.92

1.8

1.4

0.00

g/l

-0.00

212

669

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

283

1082

2.76

51.39

1.8

1.9

43.85

38.55

u/l

3.33

257

924

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1225

8216

1.76

51.03

3.1

2.3

55.10

60.13

u/l

1.59

1148

7527

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

755

4372

1.93

50.59

3.2

2.6

0.98

1.18

e6/l

0.80

424

2513

(3021447) Carbon dioxide [Partial pressure] in Venous blood

517

2616

2.15

50.36

4.8

3.6

5.80

5.86

kpa

0.72

508

2529

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

15.36

50.28

1.7

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1199

8059

1.75

49.14

6.3

2.7

33.50

36.09

u/l

0.48

1154

7591

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

281

1111

2.67

47.71

3.1

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

7.39

47.48

1.3

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1047

6824

1.77

47.44

2.2

2.3

3.35

2.89

mg/l

5.57

911

5770

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

236

856

2.89

47.24

1.8

1.4

35.99

37.72

g/l

3.52

219

726

(40768793) Breast Pathology biopsy report

127

6.26

45.91

1.5

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

899

5676

1.79

45.01

2.0

1.8

1.98

1.20

mg/l

3.03

739

4310

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3044

26922

2.14

44.36

35.3

12.9

25.37

23.42

mg/l

2.69

2814

20841

(40760888) Immunoglobulin light chains.free panel - Serum

183

605

3.14

43.10

2.2

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

10.13

42.49

1.7

1.1

—

(3019225) pH of Specimen

503

2678

2.03

42.28

7.3

3.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

189

645

3.04

42.14

4.7

3.4

1.48

1.60

mg/l

1.20

180

582

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

104

237

4.49

42.11

3.1

3.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2266

18470

1.67

41.85

5.1

4.1

—

(3017732) Neutrophils [#/volume] in Blood

364

1736

2.23

40.69

3.3

3.0

5.56

5.57

e9/l

0.00

288

1342

(3009343) pH of Capillary blood

365

1750

2.21

40.26

4.5

3.8

7.43

7.41

1.66

204

(3026008) Bacteria identified in Urine by Culture

1139

7876

1.67

40.16

3.2

3.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

427

2182

2.09

40.00

2.7

1.8

366.54

362.57

nmol/l

0.16

403

1976

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

492

2658

1.99

39.51

5.3

3.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

366

1775

2.19

39.20

4.6

3.8

5.06

5.17

kpa

1.75

359

1670

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

856

5517

1.73

39.03

4.5

4.0

400.04

509.61

ng/l

0.21

735

4487

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

128

363

3.62

38.45

2.5

1.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

249

1030

2.53

38.39

2.2

1.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

350

1693

2.19

37.68

4.5

3.8

2.26

1.79

mmol/l

1.63

286

1217

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

142

5.30

36.70

1.3

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

135

5.43

36.63

1.2

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

432

2287

2.02

36.58

5.8

6.7

1.53

1.41

mmol/l

0.82

426

2218

(3001893) Eosinophils/100 leukocytes in Pleural fluid

8.10

35.85

1.6

1.4

1.00

3.06

1.35

(3009214) Lutropin [Units/volume] in Serum or Plasma

167

584

2.95

35.64

1.6

1.4

11.44

8.46

u/l

1.76

132

480

(3045788) Cell count panel - Pleural fluid

190

4.56

35.27

1.8

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1443

10829

1.57

35.07

3.1

2.8

355.76

127.69

ug/l

16.92

1345

9926

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

7.34

34.33

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

409

2178

2.00

33.94

2.7

2.2

36.22

37.69

u/l

0.17

348

1837

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

184

696

2.74

33.94

1.2

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

7.25

32.63

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

104

288

3.69

32.37

2.5

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

6.71

32.29

1.6

1.3

65.40

59.06

0.47

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

103

287

3.67

31.78

2.5

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1427

10848

1.54

31.75

4.6

3.8

44.53

78.31

ng/l

0.87

1150

7759

(3005988) Vibrio sp identified in Specimen by Organism specific culture

103

290

3.63

31.29

2.5

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

103

292

3.61

30.98

2.5

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

335

1716

2.06

30.86

1.5

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

104

299

3.56

30.63

2.5

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

103

295

3.57

30.51

2.5

1.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1420

10903

1.52

29.48

2.3

2.2

75.73

77.97

nmol/l

2.24

1314

9585

(3012501) Base excess in Blood by calculation

149

544

2.82

29.39

5.3

4.5

2.90

2.60

mmol/l

0.58

119

362

(3023323) Follitropin [Units/volume] in Serum or Plasma

165

636

2.67

29.33

1.6

1.3

23.74

26.52

iu/l

0.46

131

540

(3022313) Gas panel - Capillary blood

267

1280

2.18

29.21

5.0

4.0

—

(3025941) Bacteria identified in Stool by Culture

278

1355

2.14

29.16

1.4

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

9.06

28.59

1.4

1.1

—

(3035880) pH of Pleural fluid

109

5.30

28.41

1.4

1.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

9.27

28.27

3.4

6.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

9.27

28.27

1.7

3.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

144

535

2.77

27.49

2.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

102

5.36

27.29

2.2

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

102

5.36

27.29

2.1

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

146

555

2.70

26.67

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

146

555

2.70

26.67

1.5

1.3

—

(40768800) Prostate Pathology biopsy report

139

4.60

26.61

1.2

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

187

806

2.40

26.30

1.6

0.33

3.88

iu/ml

0.47

165

(1616796) Gas panel - Central venous blood

147

569

2.65

25.92

4.3

3.8

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

+∞

25.03

1.1

0.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2822

25424

1.61

24.79

30.5

11.9

79.21

78.57

ml/min/173m2

0.81

2541

20446

(3044290) Cell count panel - Cerebral spinal fluid

138

530

2.67

24.72

1.8

1.3

—

(3010421) pH of Blood

157

649

2.49

24.19

5.2

4.3

7.44

7.42

3.94

148

585

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

228

1110

2.13

23.93

5.4

4.1

25.68

24.77

mmol/l

4.68

219

1022

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

145

4.26

23.49

2.1

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

486

3046

1.69

23.29

1.9

1.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

142

4.28

23.24

2.0

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

223

3.56

23.22

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

5.28

22.95

5.5

1.1

51.19

61.98

u/ml

0.10

(40767503) Oxygen content in Capillary blood by calculation

134

531

2.59

22.56

3.0

2.5

15.21

16.59

2.79

292

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

215

3.54

22.25

1.7

1.4

0.31

0.30

nmol/l

0.11

180

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

154

656

2.41

22.24

2.9

2.4

221.44

187.89

4.24

148

625

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

142

585

2.49

22.05

1.8

1.3

51.63

29.94

e6/l

0.23

110

465

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

142

585

2.49

22.05

1.9

1.4

607.27

1154.03

e6/l

0.35

113

491

(3003396) Base excess in Arterial blood by calculation

473

2986

1.68

21.98

7.1

1.46

1.22

mmol/l

0.66

374

2337

(40768443) Skin Pathology biopsy report

210

1027

2.11

21.77

1.2

—

(3023419) Bacteria identified in Sputum by Culture

115

433

2.71

21.44

2.0

2.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

6.79

21.23

1.4

1.2

5.67

6.33

ug/l

0.04

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

198

3.59

21.20

1.1

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

16.65

20.92

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

154

675

2.34

20.87

1.8

1.2

528.49

493.00

mg/l

0.52

145

629

(3027801) Oxygen [Partial pressure] in Arterial blood

470

3002

1.66

20.81

6.9

7.0

11.81

11.62

kpa

0.33

444

2850

(40768441) Liver Pathology biopsy report

100

4.75

20.78

1.4

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

470

3003

1.65

20.78

7.0

5.03

5.06

kpa

0.28

440

2854

(3013512) EKG study

1065

8163

1.44

20.24

5.2

4.1

—

(3016502) Oxygen saturation in Arterial blood

430

2706

1.67

20.13

7.4

95.17

95.07

0.11

414

2599

(40768797) Stomach Pathology biopsy report

538

3585

1.59

20.00

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

5.48

19.77

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

164

759

2.22

19.55

1.3

1.4

—

15.61

—

(3035933) Granulocytes/100 leukocytes in Blood

6.16

19.37

3.2

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

115

462

2.54

18.86

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

2567

23100

1.44

18.38

38.0

15.0

15.16

15.12

0.16

2546

22601

(3019550) Sodium [Moles/volume] in Serum or Plasma

3035

28275

1.63

18.34

34.2

15.5

139.37

139.77

mmol/l

15.28

2989

27468

(3048879) Bone marrow aspiration report

5.97

18.23

1.8

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

13.59

18.21

1.2

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1968

16948

1.38

18.13

4.0

3.0

59.22

47.68

u/l

5.87

1845

15559

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

135

3.90

17.85

2.1

1.5

—

(3021901) Oxygen saturation in Capillary blood

118

493

2.44

17.82

2.8

3.2

—

(3036489) Thrombin time

181

908

2.05

17.55

2.5

2.0

22.91

21.26

1.13

172

801

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

310

2.82

17.47

1.2

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

278

2.92

17.38

1.2

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

402

2581

1.63

17.28

3.4

3.1

277.33

212.63

ng/l

1.74

377

2363

(3049717) Cytology report of Urine Cyto stain

169

832

2.08

17.23

2.7

1.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3034

28348

1.60

17.11

34.9

15.6

3.99

mmol/l

0.00

2985

27492

(3024354) Oxygen [Partial pressure] in Venous blood

353

2198

1.68

17.10

4.3

3.0

4.73

4.60

kpa

0.42

342

2118

(3044889) 12 lead EKG panel

2176

19132

1.37

17.10

4.8

3.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

235

3.06

16.80

1.2

1.1

54.55

55.61

u/l

0.07

210

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

14.10

16.77

1.2

2.1

—

(3016018) Differential panel - Cerebral spinal fluid

257

2.96

16.72

1.8

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

16.68

1.0

0.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

7.32

16.52

1.5

1.3

108.88

151.64

ng/l

0.21

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

114

487

2.39

16.42

1.5

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

100

402

2.53

16.42

1.4

1.6

0.65

0.91

g/l

1.29

306

(3030981) Hyaline casts [#/volume] in Urine by Automated count

241

1363

1.83

16.36

2.5

2.6

0.41

0.29

e6/l

0.83

236

1327

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

381

2.56

16.19

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

257

2.92

16.12

1.4

2.45

2.99

g/l

1.28

180

(3024139) IgG subclass 3 [Mass/volume] in Serum

257

2.92

16.12

1.4

0.40

0.39

g/l

0.11

183

(3027135) IgG subclass 1 [Mass/volume] in Serum

257

2.92

16.12

1.4

6.87

6.93

g/l

0.03

183

(3002173) Hemoglobin [Mass/volume] in Arterial blood

377

2438

1.61

15.68

8.1

7.9

114.21

122.66

g/l

11.00

367

2370

(4062490) Immunoglobulin typing, IgG

257

2.88

15.52

1.5

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

4.70

15.39

1.9

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

133

628

2.16

15.14

2.5

2.2

120.92

132.00

g/l

3.96

458

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

233

1336

1.80

15.12

10.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

127

593

2.19

14.87

1.8

1.2

3.83

3.87

mmol/l

0.14

116

552

(40761536) Microorganisms panel - Urine sediment

327

2070

1.64

14.81

4.6

3.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1778

15344

1.33

14.70

3.1

2.7

—

(3024932) HLA-DR beta [Type]

4.75

14.70

1.5

1.0

—

(3023410) Appearance of Cerebral spinal fluid

244

2.87

14.58

2.2

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3068

28928

1.56

14.47

22.4

9.1

26.74

26.17

u/l

0.73

3020

27641

(3024471) HLA-A [Type]

4.68

14.46

1.0

—

(3014007) Fractional oxyhemoglobin in Arterial blood

262

1586

1.71

14.06

7.9

9.1

94.17

93.35

1.73

257

1580

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

23.86

13.77

1.2

4.9

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

6.25

13.73

1.2

1.3

1.42

1.51

mmol/l

0.12

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

147

750

2.00

13.65

1.4

1.5

1.20

1.18

g/l

0.33

142

704

(3019060) Gas panel - Arterial blood

290

1824

1.64

13.45

5.7

4.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

846

6608

1.37

13.36

1.6

1.5

19.42

20.39

nmol/l

1.13

747

5559

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

143

737

1.98

12.92

1.4

1.5

0.24

0.23

g/l

0.41

135

697

(3006922) Hepatitis E virus Ab [Presence] in Serum

148

3.28

12.85

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

225

1341

1.73

12.78

2.9

4.30

4.47

pmol/l

2.10

202

1154

(21494890) Protein electrophoresis panel - 24 hour Urine

245

2.73

12.78

1.5

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

256

1589

1.66

12.50

8.0

9.1

0.64

0.68

0.92

251

1576

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

11.65

12.29

1.8

1.2

105.40

104.03

ng/l

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

9.66

12.21

1.3

4.05

2.51

mmol/l

0.29

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

5.51

12.11

1.8

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

142

749

1.93

12.01

3.3

—

(3035350) Ketones [Presence] in Urine by Test strip

1530

13160

1.29

11.97

4.1

3.6

0.00

estimate

1.54

370

2466

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3047

28904

1.48

11.64

38.7

14.9

82.24

80.20

umol/l

2.28

3047

28896

(4281824) Cell count and differential, peritoneal fluid

127

3.34

11.62

1.2

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

110

539

2.08

11.45

2.1

2.6

33.59

35.96

umol/l

0.42

100

488

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

107

522

2.08

11.28

1.8

2.0

2515.42

4566.88

u/l

0.66

217

(3021601) Nitrite [Presence] in Urine by Test strip

1519

13123

1.28

11.23

5.5

4.8

0.00

estimate

-0.00

354

2286

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

252

1605

1.62

11.11

8.0

8.9

1.35

1.38

0.25

247

1594

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

8.05

11.06

1.8

1.4

12.92

6.44

0.45

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

420

2.20

11.05

1.2

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

478

3491

1.43

11.01

1.3

692.65

538.90

titre

0.65

747

(3010838) Calcium [Moles/time] in 24 hour Urine

441

2.16

10.97

1.8

2.1

5.27

5.01

mmol/24h

0.31

381

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

153

3.03

10.91

1.6

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

154

3.01

10.79

1.6

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

211

1296

1.67

10.74

8.4

9.5

24.37

24.33

mmol/l

0.08

206

1246

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

139

3.12

10.71

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

139

3.12

10.71

1.1

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

21.51

10.67

1.5

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

466

2.11

10.66

1.2

122.31

21.78

u/l

1.77

403

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

276

2.46

10.57

1.1

—

(3022145) Colonoscopy Study observation

373

2621

1.47

10.52

1.4

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

1528

13281

1.27

10.51

4.1

3.6

0.01

0.00

estimate

0.22

342

2185

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

9.18

10.49

1.9

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

9.18

10.49

1.9

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

9.18

10.49

1.9

1.0

—

(3015736) pH of Urine

1251

10613

1.28

10.47

3.7

3.3

5.62

5.81

0.72

604

(3008152) Bicarbonate [Moles/volume] in Arterial blood

267

1749

1.57

10.47

7.6

6.7

24.78

24.54

mmol/l

0.43

250

1664

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

+∞

10.42

1.0

0.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

242

1552

1.60

10.38

1.5

1.3

402.91

248.12

u/ml

0.55

206

1433

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

304

2059

1.52

10.25

3.3

3.9

79.54

94.53

ng/l

2.41

256

1748

(3037121) Protein [Mass/volume] in Urine

151

859

1.79

10.13

2.2

2.7

0.44

0.34

g/l

0.28

304

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2231

20368

1.27

9.87

4.3

3.8

15.01

14.90

pmol/l

1.28

2052

18334

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

232

2.53

9.76

1.3

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.53

9.76

1.4

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

133

742

1.82

9.53

1.3

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

4.61

9.52

1.9

1.0

—

(3051651) Icteric interference index of Serum or Plasma

129

3.05

9.38

3.8

3.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

250

2.42

9.28

2.9

4.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

133

749

1.81

9.25

1.3

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

13.69

9.17

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

305

2120

1.48

9.07

2.8

2.3

62.57

64.74

ml/min/173m2

0.42

125

804

(3024891) Influenza virus A+B Ag [Presence] in Specimen

114

616

1.88

9.05

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

133

755

1.79

9.02

1.3

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

123

3.03

8.84

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

274

1877

1.50

8.76

2.1

2.2

12.06

14.42

nmol/l

4.64

257

1672

(3052592) Norovirus Ag [Presence] in Stool

4.13

8.71

1.9

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

16.31

8.54

2.5

4.9

—

(3047181) Lactate [Moles/volume] in Blood

144

854

1.72

8.41

7.6

5.8

1.47

1.32

mmol/l

0.65

121

750

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

127

2.93

8.38

2.7

4.8

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

12.77

8.36

1.6

1.5

0.93

0.83

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

12.77

8.36

1.6

1.5

1.05

2.61

mg/l

—

(40758358) Immune stain study

+∞

8.33

1.0

0.0

—

(3020891) Body temperature

177

1113

1.62

8.27

5.0

4.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

696

5654

1.29

7.81

1.7

1157.86

1153.30

nmol/l

0.04

550

4234

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

502

3904

1.33

7.74

1.4

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

179

1148

1.59

7.73

1.4

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

140

2.73

7.60

1.5

5.59

8.02

u/l

0.74

120

(3028679) Herpes simplex virus Ab [Presence] in Serum

103

3.03

7.46

1.3

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2551

26921

0.80

7.45

4.2

4.6

1.37

1.43

mmol/l

10.82

2306

24699

(44786800) Granulocytes/100 leukocytes in Body fluid

7.65

7.38

1.6

1.3

20.90

25.71

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2637

27712

0.79

7.33

4.7

5.2

2.64

2.68

mmol/l

1.04

2375

25450

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

7.29

1.0

0.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

+∞

7.29

1.0

0.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

+∞

7.29

1.0

0.0

—

(3000492) Spirometry study

336

2482

1.39

7.18

1.6

1.5

—

(3047189) Immunofixation for 24 hour Urine

3.07

7.15

1.3

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

308

2.10

7.13

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

140

2.66

7.05

1.2

1.1

—

(3036603) Volume of Urine

147

2.60

6.94

1.5

1.4

1857.08

1900.29

0.14

140

(3029937) Albumin [Presence] in Urine by Test strip

847

7153

1.24

6.75

4.5

4.0

0.01

0.00

estimate

0.34

326

2222

(3007566) Smooth muscle Ab [Titer] in Serum

114

676

1.71

6.73

1.2

111.54

97.14

titre

0.23

(40761511) CBC panel - Blood by Automated count

2929

28066

1.30

6.60

26.7

12.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

10.03

6.53

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

130

2.63

6.38

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

126

785

1.63

6.20

1.9

1.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

312

2.01

6.18

1.3

1.2

37.37

39.37

u/ml

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2587

27127

0.81

6.16

4.3

4.6

4.49

4.55

mmol/l

2.20

2355

25049

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2430

25637

0.82

6.13

5.8

6.2

40.28

40.38

mmol/mol

0.19

2208

23614

(3034770) Mitochondria Ab [Titer] in Serum

113

689

1.66

6.05

1.2

—

1190.91

—

(3051611) Lipemic interference index of Serum or Plasma

242

2.12

5.95

3.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

624

7463

0.80

5.86

1.7

1.6

1.46

1.36

mmol/l

1.85

533

6227

(3041096) Erythrocytes [Presence] in Urine by Automated

806

6861

1.23

5.86

3.9

3.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

170

1152

1.50

5.81

6.5

4.6

1.60

1.65

0.26

156

1076

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.01

5.79

2.4

2.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

11.14

5.79

1.7

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

115

716

1.63

5.70

1.5

1.4

280.02

294.76

ug/g

0.36

430

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

104

640

1.64

5.41

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

2.75

5.36

1.4

1.2

1.18

0.06

g/l

—

(3032057) Clostridioides difficile [Presence] in Stool

3.19

5.31

1.9

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

165

1137

1.47

5.22

7.2

4.7

0.88

0.87

0.20

153

1065

(3003181) Sodium [Moles/volume] in Urine

449

1.75

5.20

1.4

60.22

62.74

mmol/l

0.21

359

(3039000) Anion gap in Blood

578

1.66

5.18

9.7

6.8

11.24

11.37

mmol/l

0.13

514

(3018572) Chloride [Moles/volume] in Blood

578

1.66

5.18

9.7

6.8

104.27

104.99

mmol/l

0.74

514

(3018405) Lactate [Moles/volume] in Arterial blood

146

983

1.51

5.18

3.8

1.41

mmol/l

0.02

138

963

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2621

24975

1.21

5.18

5.1

4.5

2.10

2.08

mu/l

0.12

2418

22619

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1317

11855

1.18

5.11

2.0

90.71

94.62

pmol/l

2.27

746

6103

(40757373) Influenza virus identified in Isolate

3.18

5.03

1.3

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

461

1.73

5.03

2.7

3.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.23

4.89

4.9

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

744

6389

1.21

4.86

3.8

3.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

551

1.65

4.82

1.3

1.2

1.27

6.81

u/ml

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

103

654

1.59

4.77

1.2

1.3

—

(3008295) Osmolality of Serum or Plasma

258

1.95

4.73

1.1

1.5

278.76

278.92

mosm/kgh2o

0.02

193

(3019977) pH of Arterial blood

139

2.31

4.68

4.8

2.4

7.41

7.42

0.23

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

174

2.14

4.49

1.1

339.94

265.81

mg/l

0.64

150

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

6.68

4.46

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

315

1.82

4.40

1.4

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

7.52

4.35

2.2

1.2

—

(3024928) Oxygen saturation in Venous blood

583

1.59

4.33

3.4

3.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.05

4.23

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

234

1.94

4.20

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

235

0.25

4.18

1.3

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

235

1794

1.33

4.15

2.3

2.4

8.47

22.95

au/ml

—

114

(3002523) Influenza virus A Ag [Presence] in Specimen

315

1.79

4.11

1.4

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

3.20

4.05

1.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

987

8810

1.17

4.04

2.0

2.2

171.96

237.55

u/l

1.72

937

8223

(3014891) Appearance of Pleural fluid

4.21

4.01

1.5

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

454

1.64

3.99

1.4

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1127

10171

1.16

3.99

4.4

3.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

509

1.61

3.98

1.3

1.2

43.17

42.49

u/ml

0.01

(3040151) Glucose [Moles/volume] in Capillary blood

326

1.76

3.97

6.5

29.0

6.87

7.39

mmol/l

0.86

270

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.54

3.96

1.3

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

100

2.41

3.88

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

2.57

3.88

1.4

1.2

15.60

34.29

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

185

2.01

3.88

1.1

55.05

37.96

mg/l

0.69

149

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

213

1620

1.34

3.87

1.2

1.3

105.78

58.87

au/ml

—

(3020393) Adenovirus Ag [Presence] in Stool

4.79

3.86

1.2

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

3091

30140

1.25

3.86

47.5

19.0

38.22

40.77

21.51

2925

27838

(3004451) EKG impression Narrative

145

2.15

3.86

1.1

1.3

—

(1761868) Lipid panel - Serum or Plasma

787

8898

0.85

3.86

2.9

3.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.95

3.79

2.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

106

719

1.49

3.73

1.3

1.2

45.82

42.23

u/ml

0.06

(3007461) Platelets [#/volume] in Blood

3091

30160

1.25

3.70

47.6

18.9

231.06

245.02

e9/l

20.87

3032

29223

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

267

1.81

3.69

1.0

1.1

—

29.07

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

6.68

3.67

2.4

1.2

—

(3024731) MCV [Entitic volume]

3091

30171

1.24

3.61

47.4

18.9

91.55

91.18

4.35

3059

29613

(3022493) Free Hemoglobin [Mass/volume] in Plasma

123

2.20

3.60

1.4

7.7

8885.00

63.80

mg/l

0.48

(3035941) MCH [Entitic mass]

3091

30174

1.24

3.59

47.3

18.8

30.34

30.40

0.92

3059

29618

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

104

2.32

3.59

1.1

3929.00

170.66

ng/l

—

(3026361) Erythrocytes [#/volume] in Blood

3091

30175

1.24

3.58

47.6

18.9

4.26

4.53

e12/l

120.39

3029

29118

(3010813) Leukocytes [#/volume] in Blood

3091

30176

1.24

3.57

47.6

18.9

6.81

6.74

e9/l

0.46

3030

29115

(3000963) Hemoglobin [Mass/volume] in Blood

3091

30182

1.24

3.53

47.8

19.0

127.42

136.95

g/l

172.29

3061

29621

(3043409) Potassium [Moles/volume] in Arterial blood

120

845

1.44

3.50

4.1

4.2

3.86

3.92

mmol/l

0.51

115

836

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

10.01

3.49

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

10.01

3.49

1.2

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

138

2.11

3.49

1.4

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

2.89

3.46

1.0

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2505

26002

0.86

3.45

4.0

4.1

1.34

1.30

mmol/l

1.74

2261

23631

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.66

3.39

1.4

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.66

3.39

1.3

2.1

6173.00

38442.00

e6/l

0.53

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.51

3.37

3.5

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

154

2.02

3.34

1.5

1.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.36

3.30

1.0

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

332

2731

1.24

3.30

2.2

2.4

9.25

7.93

ug/l

0.28

287

2382

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

665

1.47

3.28

1.4

1.2

2.51

2.90

u/ml

0.29

(3033086) Enterovirus NOS Ab [Titer] in Serum

8.58

3.26

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

339

1.66

3.25

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

675

1.47

3.24

1.4

1.2

3.66

6.02

u/ml

0.65

107

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

115

822

1.41

3.13

1.7

—

(3033799) Differential panel - Peritoneal fluid

2.63

3.13

1.4

1.9

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

138

2.04

3.10

1.9

1.7

1.50

3.35

u/field

0.68

(3011325) HIV 1+2 Ab [Presence] in Serum

7.51

3.05

1.0

—

(3017704) Immunofixation for Urine

146

1.99

3.04

1.3

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

106

2.18

3.02

1.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

10.01

2.98

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.24

2.96

1.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

155

1.94

2.94

2.5

1.9

8.56

18.39

umol/l

—

(3020682) Albumin/Creatinine [Ratio] in Urine

868

9571

0.88

2.89

3.9

3.8

9.68

8.62

mg/mmol

0.32

568

6094

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

351

1.61

2.87

2.0

2.2

25.78

22.79

mg/l

0.19

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

122

2.06

2.86

1.2

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

136

1.99

2.85

1.1

1.13

1.10

u/l

0.07

(3051387) C reactive protein [Mass/volume] in Capillary blood

627

1.45

2.85

3.5

3.8

30.51

27.44

mg/l

0.34

409

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

134

1000

1.35

2.85

1.1

—

1.26

u/ml

—

(40761535) Cells panel - Urine sediment

286

2357

1.23

2.82

3.4

3.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.40

2.80

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.55

2.78

1.4

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

3.92

2.77

5.1

6.3

42.78

43.47

ug/min

—

(3045424) Erythrocytes [Presence] in Urine

427

1.53

2.74

1.7

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

5.01

2.72

1.4

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.43

2.70

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

691

6172

1.15

2.70

1.7

449.20

30130650.70

pmol/l

4.58

582

5068

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

6.01

2.70

1.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

342

1.59

2.68

2.8

2.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

4.67

2.59

1.0

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

100

2.11

2.58

21.0

32.4

8.27

7.49

ug/l

1.31

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

4.01

2.56

1.6

1.8

—

(3005570) Glucose [Moles/volume] in Urine

277

1.63

2.52

1.5

1.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

890

0.67

2.51

1.3

1.8

3.75

4.48

mg/l

0.33

637

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

154

1961

0.78

2.48

1.6

1.8

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.33

2.48

1.1

1.2

76.67

91.14

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

327

1.57

2.43

1.2

—

(3012516) Albumin [Mass/volume] in Urine

827

9057

0.89

2.42

3.3

3.2

501.63

249.30

mg/l

0.84

543

5839

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.29

2.41

1.1

80.33

89.17

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

5.01

2.40

1.5

1.0

1.00

u/field

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

6.26

2.37

1.2

1.3

—

(21494755) Public health laboratory ask at order entry panel

154

1944

0.78

2.33

1.3

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

131

1008

1.31

2.32

1.3

1.2

4.45

0.85

u/ml

0.59

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.48

2.27

1.3

1.0

—

(3026480) Teichoate Ab [Titer] in Serum

3.48

2.27

1.1

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

314

0.48

2.26

1.4

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.89

2.25

1.9

2.5

—

(3044927) Protein electrophoresis panel - Urine

326

1.54

2.24

1.2

1.1

—

(1002224) Polysomnography panel

984

0.71

2.23

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

279

1.58

2.22

2.0

2.1

1.15

1.54

g/24h

0.40

139

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.11

2.22

1.0

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.05

2.21

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.20

2.21

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.69

2.20

1.3

1.1

61.67

42.11

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.62

2.14

1.8

1.6

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

5.01

2.07

1.4

1.1

5854.60

3474.60

ng/l

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.11

2.02

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

127

997

1.28

1.98

2.4

2.3

494.41

680.59

ug/l

0.26

117

940

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

171

1.70

1.96

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.08

1.96

7.6

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.08

1.96

7.6

2.9

—

(3048689) Calprotectin [Mass/mass] in Stool

344

2992

1.17

1.95

2.2

2.3

197.41

144.98

ug/g

1.34

286

2349

(3009508) Creatinine [Moles/volume] in Urine

878

9478

0.90

1.94

3.1

3.2

7.29

7.64

mmol/l

1.72

720

7970

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.97

1.93

1.0

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.75

1.93

1.0

1.1

—

(4212803) Bone marrow aspirate examination

3.75

1.93

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.65

1.86

1.8

2.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

406

0.59

1.86

1.2

1.1

2.47

2.39

u/ml

0.02

214

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.86

1.86

1.0

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

245

2871

0.84

1.85

1.7

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.98

1.84

2.5

2.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.21

1.84

1.1

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.53

1.83

1.0

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

102

1310

0.77

1.83

1.3

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.13

1.81

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

312

1.48

1.78

1.2

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.09

1.75

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.34

1.74

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.34

1.74

1.0

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.34

1.74

9.3

7.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.67

1.72

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

554

0.66

1.72

1.6

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

736

1.30

1.68

4.2

3.9

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

3.57

1.61

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

136

1.70

1.58

2.4

2.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.00

1.58

2.5

3.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.20

1.57

1.2

1.6

28.99

24.87

g/l

0.52

(3035320) C reactive protein [Mass/volume] in Body fluid

184

1.58

1.54

1.7

2.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.43

1.53

1.9

2.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

606

1.31

1.53

3.1

3.2

0.95

0.82

nmol/l

0.60

463

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

177

1.59

1.51

1.9

1.5

0.88

0.94

g/l

0.50

177

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.86

1.50

1.5

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

148

1.63

1.44

1.5

1.7

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.13

1.44

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.92

1.43

1.0

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.97

1.43

2.5

2.0

6.50

8.32

mmol/l

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.90

1.39

1.4

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

349

0.63

1.38

1.1

0.52

1.45

u/ml

—

156

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

176

1498

1.18

1.37

1.2

90.84

133.50

iu/ml

0.87

577

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

127

1.66

1.36

1.1

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

357

1.38

1.35

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

359

0.64

1.35

1.1

4.80

5.02

u/ml

0.03

183

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

207

1.50

1.35

1.4

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

307

1.41

1.34

1.1

1.3

—

nmol/l

—

(3025130) Human papilloma virus identified in Specimen

225

1.47

1.31

1.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

132

0.45

1.28

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

562

1.29

1.27

1.5

1.8

6.17

5.00

iu/l

0.20

184

(3010726) Horse dander IgE Ab [Units/volume] in Serum

317

0.63

1.27

1.2

1.1

1.10

1.33

u/ml

—

166

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

280

0.61

1.27

2.3

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

187

1.50

1.23

1.1

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

100

1.70

1.23

1.1

1168.06

1751.86

miu/ml

1.14

100

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.63

1.21

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.16

1.21

1.0

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2727

26792

1.09

1.20

4.9

4.8

5.95

6.03

mmol/l

2.54

2475

24249

(4200892) Spirometry reversibility

174

2006

0.86

1.16

1.4

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

1.16

0.0

1.1

—

0.83

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.05

1.15

7.5

6.0

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.50

1.15

1.4

2.03

0.92

ml/s/173m2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

424

0.70

1.11

1.2

1.4

—

(3011985) Renin [Units/volume] in Plasma

338

1.34

1.08

1.4

49.96

67.50

mu/l

0.40

301

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.69

1.07

1.3

1.5

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

270

1.37

1.06

2.1

2.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

403

3698

1.10

1.06

11.1

6.8

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

195

1.44

1.04

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

195

1.44

1.04

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

195

1.44

1.04

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

164

1427

1.16

1.03

3.7

3.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.96

1.03

2.0

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

138

1.52

1.02

1.1

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.74

1.02

1.2

1.5

96.62

70.40

nmol/24h

0.45

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1145

10969

1.07

1.01

4.7

3.8

4.11

1.95

ug/l

1.79

1019

9833

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

230

1.39

1.01

2.4

2.3

1.53

1.90

u/field

0.22

(3045414) Leukocytes [Presence] in Urine

135

1160

1.17

1.00

1.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.18

0.98

1.0

1.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

198

1.42

0.97

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

198

1.42

0.97

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

198

1.42

0.97

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

168

1910

0.87

0.96

1.7

1.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

648

0.78

0.96

1.4

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

188

2114

0.88

0.92

1.8

2.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

654

6168

1.07

0.92

2.8

2.7

0.77

0.71

ug/l

0.99

445

4115

(3002079) Sodium [Moles/time] in 24 hour Urine

110

1.55

0.90

1.2

147.71

168.28

mmol/24h

0.37

110

(3016750) Collection duration of Urine

168

1.43

0.89

2.3

2.1

518.87

494.51

min

0.65

122

(3006442) Creatine [Moles/volume] in Serum or Plasma

185

1.41

0.89

1.7

1.8

108.04

88.43

umol/l

0.41

185

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

135

1.48

0.89

1.5

1.4

1.52

1.54

g/l

0.12

135

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.79

0.87

1.6

1.3

32.36

29.43

nmol/l

—

(3002619) Bacteria identified in Specimen by Culture

1.78

0.84

1.4

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

615

1.21

0.83

1.5

1.4

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.61

0.81

1.2

1.8

213.77

168.31

0.77

(3044007) Cell count panel - Peritoneal fluid

1.73

0.79

1.3

2.6

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.79

0.0

1.3

—

275.95

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

0.00

0.79

0.0

1.2

—

144.21

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

234

0.68

0.77

1.2

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

234

1.33

0.77

1.3

2.1

5.71

6.52

umol/l

0.16

156

(44816559) Phosphatidylethanol [Mass/volume] in Blood

491

0.79

0.73

1.4

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.00

0.72

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

106

0.57

0.72

4.7

2.3

152.00

156.57

nmol/l

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

1.92

0.70

1.2

1.1

—

mmol/l

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

399

1.23

0.70

1.2

3.09

3.10

u/ml

0.00

131

(3006462) Nitrate [Presence] in Urine

126

1.43

0.70

2.3

3.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.55

0.69

2.3

1.8

—

(3029075) Extractable nuclear Ab panel - Serum

1.60

0.68

1.2

1.0

—

(3011648) Oxygen content in Venous blood

214

1.31

0.66

3.0

2.0

10.84

10.94

0.04

214

(3029396) Erythrocyte agglutination [Presence] in Blood

1.79

0.66

2.2

3.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

286

1.26

0.65

1.3

1.20

1.44

nmol/l

0.92

253

(3045683) HLA typing for celiac disease panel - Blood or Tissue

137

1.39

0.64

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

407

1.21

0.61

1.7

1.6

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.60

0.0

1.5

—

365.71

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.54

0.59

1.1

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.59

0.0

2.0

—

1.46

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

112

1255

0.89

0.59

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

112

0.62

0.58

1.3

1.7

8.94

8.45

mmol/l

—

107

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

253

0.75

0.57

1.5

1.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

383

1.20

0.57

1.3

1.2

1.94

5.34

u/ml

3.16

178

(36660697) Celiac disease serology panel - Serum

219

2025

1.09

0.56

1.1

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.67

0.56

1.0

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

849

0.87

0.56

1.4

1.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

168

1835

0.91

0.56

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

329

1.22

0.56

1.4

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

815

0.87

0.55

1.5

1.4

—

(3003338) MCHC [Mass/volume]

2315

22836

1.04

0.54

40.6

16.8

331.08

332.71

g/l

15.73

2295

22646

(3001019) Free T4 and TSH panel - Serum or Plasma

110

985

1.12

0.54

1.7

—

(3022621) pH of Urine by Test strip

194

1789

1.09

0.54

3.3

3.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.48

0.53

1.3

1.8

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.45

0.53

1.1

2.3

1.23

1.20

mmol/l

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.52

0.52

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

271

0.77

0.52

1.1

4.50

3.49

u/ml

—

131

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

152

1.32

0.52

1.1

1.0

18.06

13.53

iu/ml

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

575

5513

1.05

0.51

1.2

1.3

0.86

1.92

u/ml

4.83

118

1428

(4034850) Laboratory test

969

0.88

0.51

14.2

9.8

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

287

1.22

0.51

1.2

88.03

94.77

0.80

275

(3044941) Cell count panel - Synovial fluid

478

0.83

0.51

1.9

1.4

—

(3034426) Prothrombin time (PT)

1.41

0.50

1.3

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

722

0.87

0.49

1.5

2.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.52

0.48

1.3

1.5

116.29

157.04

ng/l

—

(3028300) Cannabinoids [Presence] in Urine

731

0.87

0.48

1.5

2.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

405

4250

0.95

0.47

1.2

9.02

14.27

u/ml

0.98

126

1604

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

137

1.32

0.47

1.1

—

(3027944) Amphetamines [Presence] in Urine

719

0.87

0.47

1.5

2.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

207

1930

1.08

0.46

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

579

0.86

0.46

1.8

1.7

1.09

0.79

nmol/l

1.83

480

(3027008) Opiates [Presence] in Urine

727

0.88

0.45

1.5

2.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

139

1.30

0.43

1.2

—

(3016879) Cocaine [Presence] in Urine

682

0.88

0.43

1.5

2.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

128

0.70

0.43

2.4

2.3

52.00

53.00

umol/l

—

109

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.41

0.43

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

304

1.19

0.42

1.1

1.0

1.91

2.47

u/ml

0.35

120

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.36

0.41

1.5

1.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

228

0.79

0.41

1.2

1.4

126.12

215.56

pmol/l

1.29

228

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.41

0.0

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.36

0.41

6.8

7.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.40

0.0

1.2

—

(3003577) Lead [Moles/volume] in Blood

0.00

0.40

0.0

1.2

—

0.15

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.47

0.40

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.47

0.40

1.2

1.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.47

0.40

3.8

2.4

0.60

0.65

u/field

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.47

0.40

1.0

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

133

1.28

0.38

3.2

2.5

36058.82

41858.22

ug/l

0.95

133

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.39

0.38

1.0

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

154

1440

1.07

0.35

2.3

2.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

733

0.90

0.35

1.9

1.6

9901.60

12885.61

e6/l

0.63

535

(3023511) Choriogonadotropin [Units/volume] in Urine

277

0.83

0.35

1.6

1.2

—

(3005033) Fetal Nuchal fold Thickness US

283

1.17

0.34

1.3

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.34

0.34

1.1

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

284

1.16

0.33

1.3

1.4

—

(3022689) Creatine [Moles/volume] in Urine

0.70

0.33

1.5

1.4

—

(3024263) Appearance of Synovial fluid

165

0.79

0.32

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

156

1.22

0.31

2.4

2.0

318.60

269.39

ug/min

—

(3036180) Methadone [Presence] in Urine

0.73

0.30

2.0

1.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1047

0.92

0.30

1.6

2.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

139

1.22

0.29

1.2

1.1

1.19

1.08

ratio

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.28

0.28

2.9

2.2

1.56

1.32

ug/l

0.14

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.29

0.28

1.4

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.30

0.28

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

149

1.21

0.27

2.0

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

968

0.93

0.27

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

151

1.19

0.25

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

292

1.13

0.25

1.4

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

570

0.91

0.24

1.4

2.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

243

0.86

0.23

1.1

3.38

3.99

u/ml

—

(3028707) Methadone [Presence] in Urine by Screen method

327

0.89

0.22

1.7

2.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

369

3585

1.03

0.22

4.1

4.8

31.28

32.59

1.35

263

2425

(3039443) Prostate specific Ag panel - Serum or Plasma

577

0.92

0.22

1.7

1.6

—

(3014271) Vancomycin [Susceptibility]

153

1.18

0.22

2.4

3.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.19

0.21

1.2

1.0

0.12

8.45

u/ml

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

7.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

5.1

—

381.60

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(3019150) Specific gravity of Urine by Refractometry

616

6041

1.02

0.20

4.4

4.0

1.02

kg/l

0.24

105

898

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.25

0.20

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.25

0.20

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.25

0.20

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.25

0.20

1.0

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

683

1.07

0.20

1.0

1.1

3.06

6.56

u/ml

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

394

1.09

0.19

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.15

0.19

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

270

0.89

0.19

1.8

1.4

32.33

28.61

0.16

174

(3011288) Drugs identified in Urine by Screen method

483

1.08

0.18

1.6

3.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

845

0.95

0.17

1.8

—

(3020650) Glucose [Presence] in Urine

1.11

0.17

1.0

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

690

1.06

0.16

2.3

2.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

379

1.08

0.16

1.4

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.11

0.16

6.8

7.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.77

0.15

1.2

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

369

0.92

0.15

1.7

1.5

66.70

59.83

0.54

242

(3051593) INR in Capillary blood by Coagulation assay

159

1.13

0.15

13.3

10.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.11

0.15

6.6

7.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.08

0.14

1.4

1.2

108.78

110.94

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

783

1.05

0.14

2.3

2.2

117.35

118.44

ug/min

0.01

471

(3006653) Thiamine [Moles/volume] in Blood

141

1.14

0.14

1.4

1.2

126.88

144.48

nmol/l

1.29

141

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

344

1.08

0.13

1.3

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

284

0.91

0.13

1.7

1.3

6752.76

156313.97

e6/l

2.54

196

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

345

1.07

0.12

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

345

1.07

0.12

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

345

1.07

0.12

1.3

1.4

—

(3026470) Cobalt [Mass/volume] in Blood

210

0.90

0.12

2.0

1.9

2.52

3.30

ug/l

0.62

191

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

439

4455

0.98

0.11

1.2

1.3

41.78

37.74

iu/ml

0.19

139

1366

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

240

0.92

0.11

1.0

1032.63

702.76

ng/l

2.39

148

(3000034) Microalbumin [Mass/volume] in Urine

289

1.07

0.11

2.8

2.9

23.06

30.42

mg/l

0.25

225

(44813793) Dust mix specific IgE antibody measurement

167

0.90

0.10

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.11

0.09

1.2

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.15

0.09

1.3

1.2

0.35

0.31

g/l

—

(4094501) Cardiovascular stress test using bicycle ergometer

783

1.04

0.09

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

155

0.90

0.09

1.2

1.1

—

(3008898) HLA-B27 [Presence]

796

0.97

0.08

1.1

—

(3004775) Volume in Urine collected for unspecified duration

254

1.06

0.07

2.6

2.3

872.76

631.78

1.21

162

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.03

0.07

1.0

1.3

1.78

4.74

umol/l

—

(3042733) HLA Ab [Presence] in Serum

0.86

0.07

4.4

4.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.82

0.07

2.0

1.4

7.51

8.95

ug/l

—

(3021788) Differential panel - Synovial fluid

527

0.97

0.06

1.8

1.4

—

(40768446) Kidney Pathology biopsy report

100

1.10

0.05

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

377

1.03

0.04

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

437

1.03

0.04

1.1

1.57

425.09

iu/ml

—

(3015183) Erythrocyte sedimentation rate

111

1.08

0.04

1.0

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

200

0.95

0.03

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

312

3099

1.01

0.03

1.4

—

(4146454) Self-monitoring of blood glucose

340

0.97

0.03

3.0

2.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

221

1.04

0.03

1.5

1.3

0.90

1.31

promille

0.75

166

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

298

2965

1.01

0.02

1.6

1.8

1.50

1.51

0.09

261

2583

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

888

8867

1.00

0.01

4.1

3.7

21.46

24.24

5.95

433

4165

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

106

0.94

0.01

1.0

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

112

0.98

0.00

1.2

2.3

289.02

87.41

ug/l

0.31

103

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

142

0.99

0.00

2.3

1.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

192

0.99

0.00

1.1

1.3

3.44

1.46

u/ml

—

111

(3006270) Folate [Moles/volume] in Blood

265

1.02

0.00

1.1

1.2

386.09

348.09

nmol/l

0.48

224

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.04

0.00

1.5

1.3

48.97

55.65

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

224

0.98

0.00

1.6

1.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

133

0.98

0.00

1.3

1.4

6.01

6.03

mmol/l

0.02

127

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

7.0

—

0.24

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

5.7

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.29

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.4

—

4.00

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.8

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.01

-0.00

2.4

1.4

14.80

16.90

pmol/l

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.85

-0.00

1.0

1.3

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

31.67

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

7.84

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.6

—

28.60

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

4.3

—

53.00

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.93

-0.00

1.7

1.5

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

25.20

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.4

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

1.81

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_LYMPHNODES_SECONDARY_NAS – Secondary and unspecified malignant neoplasm of lymph nodes

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Secondary and unspecified malignant neoplasm of lymph nodes

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Secondary and unspecified malignant neoplasm of lymph nodes (C3_LYMPHNODES_SECONDARY_NAS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints